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ABSTRACT 
F4 positive enterotoxigenic Escherichia coli (ETEC) is the most common pathogen 
causing neonatal diarrhea in piglets.  The pathogenesis requires the attachment of ETEC to 
the intestinal brush border, mediated by F4 fimbria.  Colostral anti-F4 antibodies and some 
non-immunoglobulin porcine skim milk proteins can bind F4 and prevent colonization and 
infection by F4-positive ETEC.  Little is known, however, about the F4-binding ability of 
porcine milk fat globule membrane (MFGM) proteins.  In addition, the knowledge of the 
absorption of porcine colostral proteins into the blood of neonatal piglets is limited, despite 
the well accepted concept that in neonatal piglets, protein absorption from the intestine is 
non-selective. 
In this study, the ability of porcine MFGM proteins to bind purified F4ac (one of the 
three subtypes of F4 fimbriae) was investigated.  Porcine MFGM proteins were first 
separated by 2D SDS-PAGE and subsequently identified by mass spectrometry.  Overlay 
western Blot was then employed to demonstrate the interaction between porcine MFGM 
proteins and purified F4ac.  Several proteins from porcine MFGM reacted with F4ac, and of 
these, lactadherin, butyrophilin, adipophilin, and acyl-CoA synthetase 3 reacted strongly.  
The biological function of these proteins in vivo was not investigated but it is possible that 
their interaction with F4ac positive ETEC interferes with bacterial attachment and 
colonization.  
In order to investigate protein absorption by neonatal piglets after natural suckling, the 
protein profiles of the plasma of pre-suckling and 24 h post-suckling neonatal piglets were 
studied by 2D SDS-PAGE.  Those plasma proteins that increased prominently after suckling 
were then identified by mass spectrometry.  Only immunoglobulins were unequivocally 
determined to be absorbed, because they were absent before suckling and present in large 
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quantity in plasma 24 h after suckling.  The absorption of other colostral proteins was either 
equivocal or not detectable by our detection methods.  These results suggest that, unlike 
immunoglobulins, major non-immunoglobulin proteins in porcine colostrum may not be 
absorbed into systemic circulation in substantial amounts. 
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1. Literature review 
1.1. Introduction 
It is well known that colostrum and milk provide tremendous immune protection for 
neonates against local intestinal and systemic infectious diseases.  Farm animals, including 
pigs, are born hypogammaglobulinemic (low concentration of immunoglobulin in the blood) 
because the epitheliochorial placenta prevents transfer of large proteins from dam to fetus 
during gestation.  After suckling, a large amount of maternal immunoglobulins is absorbed 
from the gut of the neonates into the bloodstream, resulting in neonatal protection against 
pathogens.  The importance of this passive transfer of immunoglobulins is well 
characterized and indisputable, but the ability to absorb immunoglobulins decreases sharply 
after 24 h of age [1].  There is, however, an increasing body of evidence demonstrating that 
non-immunoglobulin colostral and milk proteins are also involved in neonatal protection 
against disease.  Failure of early proper colostral ingestion by neonates results in increased 
neonatal morbidity and mortality.  
Escherichia coli (E. coli) causes a variety of intestinal and systemic diseases in neonatal 
and postweaning pigs and it is one of the most important pathogens in the swine industry.  
Neonatal diarrhea, which causes significant direct and indirect economic losses in the modern 
swine industry, is most commonly caused by enterotoxigenic E. coli (ETEC).  Fimbrial 
adhesins, exotoxins and endotoxin are the major virulence factors of ETEC.  Fimbrial 
adhesion of ETEC to the intestine is the necessary first step of infection leading to neonatal 
diarrhea.  Anti-fimbrial antibodies in colostrum and milk prevent attachment of ETEC to the 
intestinal mucosa and protect piglets against diarrhea.  In addition, various 
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non-immunoglobulin proteins in porcine milk have been reported to provide antibacterial 
defenses in vitro.  Several proteins isolated from porcine skim milk fractions have been 
shown to bind either F4-fimbriae or endotoxin of E. coli [2, 3] or to kill bacteria in vitro [4].  
Investigation of the potential defense role of the fat fraction of porcine milk has been limited.  
In addition, little is known about potential absorption of non-immunoglobulin defense 
proteins into the systemic circulation of neonates.  Accordingly, the aims of studies 
presented in this thesis were to investigate the presence of F4-binding proteins in milk fat 
globule membrane (MFGM) isolated from the fat fraction of porcine milk and to determine 
the absorption of non-immunoglobulin proteins from milk by neonatal piglets.  
1.2. Porcine milk proteins 
1.2.1. Fractions of milk 
By differential centrifugation, milk can be divided into four main fractions, namely milk 
fat, skim milk, whey milk and caseins.  Milk fat is separated from the whole milk by low 
speed centrifugation.  Skim milk refers to the non-fat fraction of milk.  After 
ultracentrifugation, caseins can be pelleted from the clear supernatant termed whey milk.  
One should note, however, that the separation of these fractions by centrifugation procedures 
is not 100% efficient and cross contamination of components among these fractions cannot be 
completely eliminated.  
1.2.2. Milk fat globule membrane proteins 
In milk, fat appears as droplets which are called milk fat globules.  These globules 
consist of a central triglyceride core enclosed by the milk fat globule membrane (MFGM) 
which has three layers.  The innermost layer is derived from the endoplasmic reticulum (ER) 
of mammary glandular epithelium, and the outer double layers are formed from apical 
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membranes of the mammary glandular epithelial cells.  The proteins associated with the 
MFGM are called MFGM proteins.  Eight major and many minor proteins have been 
identified in human, murine and bovine MFGM [5, 6]. 
1.2.2.1. Major MFGM proteins 
1.2.2.1.1. Mucin 1 
Mucin 1 (MUC1) is a highly glycosylated large protein (molecular weight [MW] ranges 
from 160 kDa to > 200 kDa), and is present in ruminant, mouse and human MFGM as well as 
in many tissues (e.g. salivary gland, kidney, esophageal epithelium and stomach) [7, 8].  
MUC1 is a filamentous type I membrane protein which has a single transmembrane anchor, 
an N-terminal exoplasmic domain and a short C-terminal cytoplasmic tail [6].  The amino 
acid sequence of the exoplasmic domain has a repetitive character [6].  Although 
structurally a membrane protein, MUC1 is not tightly bound to the MFGM, since cooling and 
stirring are sufficient to cause it to release [9]; accordingly, MUC1 is found in both MFGM 
and skim milk [10]. 
MUC1 is present in the mucosal secretion that forms a physical barrier protecting 
against the mucosal invasion of pathogens [8].  The carbohydrate structural moiety of 
MUC1 interacts with various pathogens in vitro; thus, a potential in vivo defense role has 
been hypothesized [10].  Mucin present in human MFGM inhibited binding of S-fimbriated 
E. coli to buccal epithelial cells [11].  Bovine MUC1 interfered with murine rotaviral 
infectivity both in vitro and in vivo [12].  Human MUC1 was demonstrated to aggregate 
poxvirus and inhibit its activity [13] and to inhibit infection of human T lymphoblastoid cells 
by HIV-1 [14].   
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1.2.2.1.2. Xanthine dehydrogenase/oxidase  
Xanthine dehydrogenase/oxidase (XDH/XO) is a homodimer with MW ~ 300 kDa [6].  
Each monomer has four domains: a molybdopterin cofactor, two Fe2/S2 clusters and one 
flavin adenine dinucleotide (FAD) [15].  XDH/XO is present in a variety of tissues including 
lactational mammary glandular epithelium and MFGM [16]. 
The enzymatic function of XDH/XO has been well studied [15].  XDH/XO catalyzes 
the oxidation of purines to uric acid by addition of oxygen from H2O [6];  however, various 
inactive forms of the enzyme have been found, the functions of which are not clear [17, 18].  
Two inactive forms (desulfo and demolybdo) of the enzyme have been reported and 
XDH/XO purified from milk is often inactive [6, 19, 20].  Although it has been suggested 
that the inactive XDH/XO can be activated in the gut [21], it is not clear whether the main 
function of XDH/XO in milk is as an enzyme.  Alternatively, XDH/XO has been suspected 
to play an important role during the secretion of milk fat, facilitated by formation of a 
complex with butyrophilin and adipophilin [6, 22, 23].  This heterotrimer model of milk fat 
secretion has been previously well documented and accepted even though a recent study 
suggested that butyrophilin has a more dominant role than the other two proteins [24].  
Reactive oxygen species generated by XDH/XO may also act as antibacterial components [6, 
25, 26]. 
1.2.2.1.3. Mucin 15 
Mucin 15 (MUC15) from MFGM was previously poorly characterized.  This protein is 
highly glycosylated and stains well with Periodic acid-Schiff (PAS) stain.  Several MFGM 
proteins stain positive with PAS and initially the name PAS III was used for this protein.  
Recently, PAS III from bovine milk has been characterized and renamed MUC15 [27].  
Carbohydrates represent ~65% of the total molecular weight of bovine MUC15 [28].  Based 
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on PAGE migration, its molecular weight is 95 kDa to over 100 kDa [6].  There is no 
antigenic cross reactivity between PAS III and MUC1 [6].  The primary amino acid 
sequence shows that MUC15 is a type I membrane protein.  It has an N-terminal exoplasmic 
domain which is rich in serine, threonine, and proline, a transmembrane domain and a 
C-terminal cytoplasmic tail.  The same study showed that the MUC15 gene is expressed in a 
wide range of human and bovine parenchymal organs, lymphoid tissues, reproductive organs 
and on various mucosal surfaces [27, 29-31].  The function of MUC15 is not known.   
1.2.2.1.4. CD36 
CD36 is a highly glycosylated integral protein of the MFGM and is also present on 
monocytes, platelets, microvascular endothelial cells, adipocytes and many other tissues [6, 
32].  Its structure is characterized by the presence of one transmembrane domain at both 
N-terminus and C-terminus and an exoplasmic hydrophobic region [33]. 
The functions of CD36, which acts as an adhesive protein and binds to a large number of 
ligands, have been reviewed extensively [32, 33].  Briefly, CD36 is a multifunctional protein 
involved, inter alia, in coagulation, apoptosis and atherosclerosis.  It binds to collagen and 
contributes to platelet activation and aggregation.  CD36 acts as a receptor for 
thrombospondin which can induce apoptosis via activated FAS ligand and associated caspase 
cascades.  In addition, CD36 acts as a scavenger receptor and binds to apoptotic cells 
facilitating their phagocytosis [34].  CD36 on the surface of macrophages mediates the 
intake of oxidized low density lipoproteins (LDL) which are associated with formation of the 
foam cells characteristic of atherosclerosis [32, 35, 36].  This binding capacity to LDL [37] 
has recently become a focus of very active research.  CD36 expressed on vascular 
endothelial cells and monocytes binds to Plasmodium falciparum infected red blood cells via 
P. falciparum-erythrocyte-membrane-protein-1 (PfEMP-1), assisting the localization of the 
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organism in peripheral tissues and the progression of infection [38, 39]. 
Although the function of CD36 in milk and the mammary gland is not clear, it has been 
hypothesized that CD36 acts as a thrombospondin receptor or functions as a transporter of 
long-chain fatty acids [6].  Recent data showed that CD36 and fatty acid binding protein 
(FABP) function in concert to increase the transport of fatty acid in heart [40], and perhaps 
CD36 and FABP have the same function in the milk, since FABP is also one of the major 
MFGM proteins [6].  Another possibility is that CD36 together with lactadherin, another 
major MFGM protein, facilitates the clearance of apoptotic cells in the mammary gland [34]. 
1.2.2.1.5. Butyrophilin 
Butyrophilin is the most abundant protein on bovine MFGM, comprising over 20% of 
the total MFGM proteins [41, 42].  Butyrophilin, named from the Greek roots “butyros” 
(butter) and “philos” (loving), has an affinity for butter fat [43].  Butyrophilin is a type I 
membrane glycoprotein [44] considered to be an integral protein of the MFGM because it 
resists extraction by chaotropic agents and nonionic detergents [43].  Reducing agents (e.g. 
2-mercaptoethanol ) are needed to solubilize butyrophilin [45], which suggests that a 
disulfide bond stabilizes butyrophilin on the MFGM. 
Butyrophilin belongs to the immunoglobulin superfamily based on its two 
immunoglobulin-like N-terminal folds (IgI and IgC1) [43].  A 27 hydrophobic amino acid 
segment of butyrophilin serves as the transmembrane domain.  The C-terminal cytoplasmic 
segment is a highly conserved region known as B30.2 and is suspected to be the binding 
domain for xanthine dehydrogenase/oxidase [6]. 
Butyrophilin has a regulatory function in milk fat secretion from mammary epithelial 
cells.  Secretion of milk lipid in mice with disruption or elimination of the butyrophilin gene 
is severely compromised in comparison to wild-type animals.  As a result of butyrophilin 
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gene ablation, unstable and extremely large lipid droplets (up to 7 times larger than the 
diameter of wild-type) lacking MFGM accumulate in the mammary luminal spaces.  The 
concentration of skim-milk proteins is not affected.  Interestingly, probably due to the 
inability to get sufficient milk, approximately half the pups suckling dams lacking the 
butyrophilin gene died within the first 20 days, and weaning weights of the surviving pups 
were 60-80% of those suckling wild-type mice [46]. 
The concept that milk fat secretion is mediated by a complex of butyrophilin, XDH/XO 
and adipophilin is well accepted [47-49].  A recent study based on freeze-fracture 
immunocytochemistry suggests, however, that butyrophilin self-aggregates and alone 
controls the milk fat secretion [24]. 
It is not clear whether butyrophilin has any additional functions, even though it belongs 
to the immunoglobulin superfamily which contains a variety of adhesive proteins involved in 
important biological functions [50].  Several  butyrophilin-like proteins have either 
potential receptor functions [51, 52] or T-cell regulatory functions [53, 54], but the biological 
importance of these newly identified activities has not been defined. 
1.2.2.1.6. Lactadherin 
Lactadherin, a 46 kDa peripheral glycoprotein, is a major protein on MFGM.  There is 
no transmembrane hydrophobic sequence in its primary structure [6].  Amino acid 
sequencing revealed that lactadherin has N-terminal epidermal growth factor (EGF)-like 
domain(s) which contains an RGD cell adhesion sequence and C-terminal tandem repeats 
similar to C1 and C2 domains of coagulation factors V and VIII [6].  There is a putative 
amphipathic phospholipid-binding α-helix structure that may serve as a binding site to the 
membrane.  Lactadherin is also found in several other cells, e.g. sperm and macrophages 
[6].  
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Multiple functions of lactadherin have been reported.  The RGD motif in the EGF-like 
domain may mediate binding to integrin and this has been confirmed for bovine lactadherin 
[55].  Lactadherin is involved in cellular adhesion [56], neovascularization [57] and 
clearance of apoptotic cells [47, 58].  Lactadherin (aka p47) is also expressed on the 
membrane of sperm where it may be involved in adhesion during fertilization [59].  Purified 
porcine lactadherin is able to bind glycoprotein ZP on the zona pellucida of oocytes [60]. 
Our understanding of the functions of lactadherin in colostrum and milk (including in 
MFGM) is limited.  Lactadherin binds to apoptotic cells and facilitates their phagocytosis 
during postlactational mammary involution [47].  Human, but not bovine lactadherin, 
possesses anti-rotaviral activity in vitro [61] and is associated with protection of human 
infants against rotaviral infection [62].  Porcine lactadherin has binding affinity for 
F4ac-fimbriae and decreases binding of F4ac E. coli to intestinal villi ex vivo [3].   
1.2.2.1.7. Adipocyte differentiation-related protein (Adipophilin) 
This MFGM protein has been overlooked for a long time because its molecular weight is 
similar to that of lactadherin (46 kDa) [6]; thus, when subjected to one-dimensional (1D) 
SDS-PAGE, adipophilin and lactadherin are not separated.  Using two-dimensional (2D) 
SDS-PAGE, however, they are visualized as two different proteins with similar molecular 
weights but different isoelectric points [6].  Initially, this protein was thought to be 
specifically expressed in adipocytes and termed adipocyte differentiation-related protein [63]; 
however, later it was demonstrated that it is also expressed in a variety of cultured cell and in 
tissues such as lactating mammary epithelium, steroid-producing adrenal cortical cells, 
Sertoli and Leydig cells in the testis, and in lipid laden hepatocytes in the cirrhotic liver of 
alcoholics [64].  Now, the name adipophilin is being more preferably used for this protein [6, 
64, 65]. 
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The amino acid sequence of adipophilin is similar to those of perilipin and TIP47; 
accordingly,  these three proteins are now called “PAT proteins” (perilipin, adipophilin and 
TIP47) [6].  PAT proteins are all associated with lipid droplets [66, 67].  Since PAT proteins 
do not possess hydrophobic amino acids, the interaction between these proteins and lipid 
droplets has not been clear [63, 68].  More recently, however, an adipophilin fragment 
between 189 and 205 amino acids has been suggested to have an α-helical conformation 
proposed to interact with lipid droplets. [65]. 
The function of adipophilin still requires clarification.  The association of adipophilin 
with cytoplasmic lipid droplets suggests that it is involved in lipid storage and metabolism 
[69].  Adipophilin enhances in vitro uptake of long-chain fatty acids [70].  It may be 
involved in lipid biogenesis, since it was recently found that lipid droplets are cupped, but not 
enclosed, by the endoplasmic reticulum at an adipophilin-rich site [71].  An association 
between the expression of adipophilin and development of artherosclerosis has also been 
demonstrated [72].  In mammary epithelium, complexing of adipophilin with butyrophilin 
and xanthine dehydrogenase/oxidase may facilitate lipid secretion in milk [47-49].   
1.2.2.1.8. Fatty acid binding protein 
Fatty acid binding protein (FABP) of MFGM appears as a ~13 kDa protein band in 
SDS-PAGE [6].  It was initially called mammary-derived growth inhibitor based on its 
ability to inhibit growth of mammary carcinoma cells [73]  and later found to have a similar 
amino acid sequence to heart FABP in rats [74].  Subsequently it was determined that FABP 
in MFGM consists of a mixture of heart type and adipocyte type FABP [75], with the heart 
type predominating [6].  The characteristic of the structure of FABP is the presence of 
β-barrel composed of 10 antiparallel β-strands [76], which create a cavity lined by both 
hydrophobic and polar amino acids forming the binding ligands for fatty acids [76]. 
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The function of milk FABP is not yet clear.  It may transport intracellular fatty acids, 
control lipid metabolism and increase cytoplasmic lipid droplets [6].  FABP inhibits growth 
and stimulates differentiation of mammary epithelium [6], but any growth regulatory function 
has not been determined for the intestinal epithelium of neonates.  Using affinity 
chromatography heart FABP was identified as one of the F4ac-fimbrial-binding proteins in 
porcine skim milk [3].  More studies are needed to determine if FABP is involved in innate 
immunity. 
1.2.2.2. MFGM proteomics 
The protein components of MFGM have recently attracted attention from various 
research groups working on different species even though the comparative knowledge about 
MFGM protein profiles is still limited.  To date, MFGM proteins have been characterized 
only in human, mouse and bovine milk [5, 26, 77-79].  Using various experimental 
approaches, 107 proteins (derived from 39 genes) have been identified in human MFGM [78], 
120 proteins in bovine MFGM [79] and 29 in mouse MFGM [5], but interestingly, only 15 of 
the bovine proteins were the same as those from human and mouse MFGM [79].  
Accordingly, these results may indicate that differences exist in MFGM proteomes among 
various mammalian species; however, it is also possible that these differences were due to 
different experimental methodology employed.  MFGM proteins can be grouped, based on 
function, into proteins involved in membrane trafficking, cell signaling, fat 
transport/metabolism, protein synthesis/folding, immune proteins and residual milk proteins.  
Also interesting to note is that the expression and concentration of several bovine MFGM 
proteins changes during the course of lactation.  Twenty six proteins, including several 
major MFGM proteins, are up-regulated whereas 19 proteins, including some lipoproteins, 
are down-regulated [49, 80]. 
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1.2.3. Immune functions of porcine skim milk proteins 
The physico-chemical composition of porcine milk proteins has been comprehensively 
reviewed [81].  This section briefly summarizes some skim milk proteins in porcine milk 
that have immune functions.  Immune components in the milk have been previously 
reviewed by different groups [4, 82, 83]. 
1.2.3.1. Immunoglobulins 
Immunoglobulins are a well known immune component in colostrum and milk, 
providing an unequivocal protective activity against pathogens.  This protection is 
considered to be specific, i.e., specific maternal antibody binds to specific antigen after the 
dam has been exposed or vaccinated with this antigen. 
1.2.3.2. Caseins 
A specific characteristic of porcine milk is the high concentration of caseins [81].  
Caseins can be subdivided into α-casein, β-casein, κ-casein and casein micelles.  Casein is a 
source of amino acids for the neonates; in addition, it has been increasingly reported to have 
potential immune functions.  Antimicrobial activities have been demonstrated for many 
casein-derived peptides from human [84], bovine [85-87] and rabbit milk [88].  
Semi-purified porcine casocidin-I has growth inhibitory activity against a wide spectrum of 
porcine pathogens [4].  Alpha-S1 casein and β-casein have binding affinity to F4 and 
lipopolysaccharide (LPS) isolated from E. coli [2, 3].  Further investigations are needed to 
determine if various caseins or their fragments are important defense components in vivo.  
1.2.3.3. Lactoferrin  
Lactoferrin is an iron-binding protein present in milk, other body fluids and neutrophils 
[89].  The antimicrobial activity of human and bovine lactoferrin and its peptides has been 
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well documented [90-92].  Bovine lactoferrin protects germ-free piglets from endotoxic 
shock [93].  Porcine lactoferrin has binding affinity for LPS and pepsin-digested porcine 
lactoferrin inhibits growth of a wide spectrum of porcine bacterial pathogens [2].  
Several other proteins in porcine skim milk exhibit binding affinity for LPS and F4ac in 
addition to those mentioned above; however, their biological relevance in vivo has not been 
determined [2, 3]. 
1.3. Pathogenic E. coli in pigs 
Escherichia coli (E. coli) is a gram-negative, rod-like bacterium and is one of the major 
bacterial components of the normal intestinal flora in many species; however, some E. coli 
strains are pathogenic and can cause intestinal and/or extra-intestinal diseases in humans and 
animals.  Pathogenic E. coli can cause a variety of diseases in pigs, including neonatal and 
post-weaning diarrhea, septicemia, enterotoxemia/edema disease, mastitis and urinary tract 
infection.  This section is limited to a review of E. coli-associated porcine diarrhea and 
septicemia, which are the most important E. coli-associated diseases in pigs. 
1.3.1. Diarrheagenic E. coli 
Intestinal E. coli infection has been intensively studied and several diarrheagenic 
pathotypes of E. coli have been described in humans and animals.  In pigs, enterotoxigenic E. 
coli (ETEC) is the most common type and causes neonatal and post-weaning diarrhea (PWD) 
[94].  Enteropathogenic E. coli (EPEC) is also associated with PWD. 
1.3.1.1. Enterotoxigenic E. coli (ETEC) 
Neonatal diarrhea causes significant economic loss in the pig industry, with ETEC being 
one of the most important pathogens.  Affected piglets are usually under one week old and 
suffer varying degrees of watery diarrhea, dehydration and metabolic acidosis [95].  The 
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first step of bacterial colonization is the adhesin-mediated attachment to the intestinal 
epithelium [94].  Adhesins are important virulence factors of ETEC.  ETEC strains that 
cause neonatal diarrhea may express F4, F5, F6 and F41 fimbrial adhesins, with F4-positive 
(F4+) strains being most common [95].  Adhesin involved in diffuse adherence (AIDA), a 
recently identified non-fimbrial adhesin, is also expressed in some porcine ETEC [96].  
After attachment, ETEC multiply and excrete enterotoxins (LT, STa, STb, EAST1) which 
cause disturbed ion and water exchange by different molecular mechanisms, inducing 
secretory diarrhea in the absence of morphological changes of the intestinal epithelium [96, 
97]. 
ETEC can also cause diarrhea in post-weaning pigs, usually in the first week after 
weaning.  PWD is usually not as profuse as neonatal diarrhea. The feces are less watery and 
animals demonstrate a loss of weight gain [98].  Some ETEC strains can cause both neonatal 
diarrhea and PWD, e.g. some F4+ strains; however, other ETEC strains, such as F18+ E. coli, 
cause disease only in the post-weaning age group [95].  Some strains that typically cause 
edema disease are also associated with PWD and these two disease entities can be concurrent 
in one individual [95].  Adhesins involved in post-weaning ETEC diarrhea include F4, F18 
and AIDA-I [95, 97].  That different strains of ETEC can cause disease in different age 
groups of pigs is probably due to age-related changes in expression of receptors in intestinal 
brush border and mucus [99, 100]. 
1.3.1.2. Enteropathogenic E. coli (EPEC) 
Porcine EPEC strains typically cause PWD.  EPEC do not express fimbrial adhesins 
[97]; instead, due to a non-fimbrial adhesin called intimin, they cause attaching and effacing 
lesions of the brush border of the intestinal epithelial cells [101].  The mechanism of 
diarrhea caused by EPEC is not entirely understood.  Morphological changes of the 
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intestinal mucosal surface which cause malabsorption may be one explanation; however, 
other mechanisms may also be involved [97]. 
1.3.2. E. coli septicemia and endotoxemia 
Extraintestinal E. coli strains can pass through the intestinal epithelium, enter the blood 
stream and cause septicemia with the release of LPS (aka endotoxin).  Occasionally, LPS 
from ETEC may be absorbed from the intestine into the circulation, resulting in endotoxemia 
[96].  LPS triggers activation of macrophages and may induce an uncontrolled cascade of 
cytokine secretion resulting in shock and death [102]. 
1.3.3. Fimbrial adhesins 
Fimbriae are rod-like protein structures on the surface of bacteria.  ETEC typically use 
fimbriae to attach to the intestinal epithelial cells and this attachment is thought to be the first 
step of colonization.  In pigs, ETEC may express F4, F5, F6, F18 or F41 fimbrial adhesins.  
ETEC fimbriae are composed of multiple repeating major subunits and several different 
minor subunits.  Fimbriae bind to receptors on the brush border of the intestinal epithelial 
cell or to receptors in intestinal mucus.  The binding between fimbriae and receptors is 
based on a lectin-glycan interaction, namely, a carbohydrate-binding domain of a protein 
binds to a carbohydrate moiety of a receptor.  Accordingly, fimbrial receptors are most 
commonly glycoproteins or glycolipids.   
1.3.3.1. F4 fimbriae 
F4+ E. coli is the most common ETEC strain in pigs, causing both neonatal and 
post-weaning diarrhea [95].  F4 fimbriae are long filamentous surface appendages.  F4 is 
divided into 3 subtypes, namely, F4ab, F4ac and F4ad, based on differences in primary amino 
acid sequences of the major FaeG subunit [99, 103].  The antigenically conserved segment 
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is “a”, while “b”, “c” and “d” refer to the variable antigenic segments.  F4ac-positive ETEC 
is the most prevalent strain of porcine ETEC [104]. 
In addition to the major FaeG subunit, there are also several minor subunits, namely, 
FaeC, FaeD, FaeE, FaeF, FaeH, FaeI and probably FaeJ [99].  However, the major FaeG 
subunit, consisting of a ~ 27.5 kDa protein, is considered to possess both structural and 
adhesive functions [97].  F4 fimbriae have multiple exposed binding sites that recognize and 
bind to corresponding receptors [97]. 
Based on genetically determined differences in the ability of porcine intestines to bind 
the fimbrial subtypes F4ab, F4ac and F4ad E. coli, 6 different phenotypes (A-F) of pigs have 
been identified [105, 106] (Table 1.1).  Phenotype A pigs bind all three F4 subtypes; 
phenotype B binds F4ab and F4ac; phenotype C binds F4ab and F4ad; phenotype D binds 
F4ad; phenotype E lacks binding and phenotype F binds only F4ab.  It should be noted that 
phenotype C is poorly characterized and there is some concern that the binding of F4ab to 
this phenotype is artifactual, thus, phenotype C may be the same as phenotype D [107]. 
Intestinal receptors for F4 fimbriae are either glycoproteins or glycolipids [99, 107].  
Van den Broeck and co-workers reviewed in detail the previous efforts to characterize F4 
intestinal receptors [99].  The molecular weights of intestinal brush border receptors for 
different F4 subtypes are summarized in Table 1.2.  A 4-receptor model (receptor bcd, bc, b 
and d) was established to explain the differences in susceptibility of various host phenotypes 
to the 3 subtypes of F4 E. coli [99] (Table 1.1).  The bcd receptor has affinity for all 3 F4 
fimbria subtypes; bc for F4ab and F4ac; b for F4ab and d for F4ad.  Thus, phenotype A pigs 
have both bcd and bc receptors; phenotype B animals the bc receptor, phenotype C and D the 
d receptor (considering phenotype C may be the same as phenotype D); phenotype E lacks 
receptors for any F4 fimbriae; and phenotype F pigs have the b receptor [99].  Further, 
within the receptors summarized in Table 1.2, the 210 and 240 kDa proteins may represent 
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the bc receptor, the 74 kDa protein the b receptor and the set of 45-70 kDa proteins the bcd 
receptor [99].  The d receptor is likely a neutral glycosphingolipid [99].  In addition, F4ab 
and F4ac receptors have also been demonstrated in intestinal mucus (Table 1.2).  F4ad 
mucus receptor(s) have not yet been investigated. 
β-galactose residues are thought to be a basic carbohydrate structure recognized and 
bound by the carbohydrate-binding domain on F4 fimbriae.  Galβ1-3GalNAc and 
Fucα1-2Galβ1-3/4GlcNAc have been proposed to be the main functional structures of 
F4-receptors [97]. 
 
Table 1.1 F4 intestinal brush border receptor model  
Phenotypes Receptors Binding ability to F4 subtypes 
bcd ab, ac and ad A 
bc ab and ac 
B bc ab and ac 
C (same as D?) d ab (artifactual?) and ad 
D d ad 
E No receptors No binding 
F b ab 
 
Table 1.2 Molecular weights of intestinal F4 receptors 
F4 subtypes Brush border receptors (kDa) Mucus receptors (kDa) 
ab 16, 40-70, 74, 210 and 240 25, 30, 40-42, 60 
ac 40-70, 210 and 240 25, 30, 60 
ad 45-75 N/A 
N/A: Not available 
1.3.3.2. F5 fimbriae 
F5+ ETEC infect pigs, cattle and sheep.  F5 is a long fibrillar protein, the major 18.5 
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kDa subunit (FanC) of which serves as the adhesin [108, 109].  Since F5 mainly attaches to 
intestine of preweaning pigs, it most frequently causes diarrhea in this age group [96].  The 
gangliosides N-glycolylneuraminyl-lactosyl-ceramide (NeuGc-Gm3) and 
N-glycolylsialoparagloboside (NeuGc-SPG) serve as receptors for F5 fimbriae [109]. 
1.3.3.3. F6 fimbriae 
F6 fimbriae are short, pili-like structures identified only on porcine ETEC.  F6+ E. coli 
mainly cause disease in neonatal pigs.  The F6 fimbria consists of a major repeating subunit 
(FasA) and several minor subunits, one of which, FasG, acts as the adhesin.  This was the 
first recognition that a minor ETEC fimbrial subunit serves as adhesin [110].  The brush 
border receptors of F6 have not yet been definitely characterized but are either glycoprotein 
or glycolipid in nature [111].  Interestingly, that the susceptibility of piglets to F6-positive 
ETEC declines with increasing age is associated with an increased concentration of mucus 
receptors rather than a decrease in density of receptors in brush border [100].  Thus, it has 
been thought that the increased mucus receptors in older pigs bind to F6-positive ETEC and 
facilitate the clearance of the ETEC by intestinal peristalsis [100].   
1.3.3.4. F18 fimbriae  
F18ac is associated with PWD worldwide [95].  F18 fimbria consists of the two 
antigenically different variants F18ab and F18ac [98].    The major subunit of F18 is FedA, 
but again the adhesin is located on one of the minor subunits, FedF [112].  The expression of 
the F18 receptor has been shown to increase with age [113].  Although the nature of F18 
receptor is not fully understood to date, it is suspected that H-2 histo-blood group antigens 
(HBGAs) and A-2 HBGAs may be involved in the binding of F18+ E. coli to the host [113]. 
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1.3.3.5. F41 fimbriae  
F41 fimbriae are filamentous structures, composed of major subunits with a molecular 
weight of 29.5 kDa [114, 115].  Although F41 is mostly co-expressed with F5 fimbriae, F41 
alone was shown to be able to mediate ETEC adherence to intestinal epithelium [96].  
Characterization of the F41 receptor(s) is lacking. 
1.3.4. Non-fimbrial adhesins 
Several non-fimbrial adhesins have been discovered in recent years and adhesin 
involved in diffuse adherence (AIDA) and intimin have attracted the most interest in 
veterinary medicine. 
1.3.4.1. AIDA-I 
AIDA-I was first identified in human diffusely adhering E. coli (DAEC) isolated from 
infantile diarrhea [116].  Later, the prevalence of AIDA-I positive E. coli was found to be 
higher in porcine than in human diarrhea cases [117, 118].  AIDA-I isolated from porcine E. 
coli had a similar molecular weight (100 kDa) and relatively high amino acid homology 
(78-87%) with the AIDA-I adhesin expressed by human AIDA-I positive E. coli strain 2787 
[119].  IgG Fc binding protein (~120 kDa) was identified as the most likely candidate to 
serve as a potential receptor in intestinal mucus for AIDA-I adhesin [119, 120].  
1.3.4.2. Intimin 
Porcine EPEC typically do not express fimbrial adhesins [96].  They attach intimately 
to the enterocytes via a non-fimbrial adhesin called intimin, which is a 94 kDa outer 
membrane protein [121].  Intimin binds to a translocated intimin receptor (TIR) which is 
expressed by EPEC and then transferred to the host enterocytes [101].  After attachment to 
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the brush border, EPEC causes attaching and effacing lesions, characterized by loss of 
microvilli and formation of a pedestal-like extrusion on the enterocyte at the site of adherence.  
Ultrastructurally, a dense plaque of cytoskeletal filaments is often seen in the pedestal-like 
structure [97]. 
1.4. Protein absorption by the porcine intestine 
1.4.1. Non-selective protein absorption by the intestine of neonatal piglets 
It is now accepted as dogma that the intestine of the neonatal piglet can non-selectively 
absorb proteins and macromolecules into the bloodstream.  The absorption of proteins from 
gut to blood (so-called “transcytosis”) is thought to consists of three steps: 1) endocytosis, i.e., 
the uptake of macromolecules by the enterocyte; 2) intracellular processing of the molecules; 
and 3) exocytosis, i.e., the release of the macromolecules into the blood [122]. 
Intestinal absorption of a variety of proteins and macro- and micromolecules has been 
investigated in pigs.  These includes bovine IgG [123], porcine IgG [124, 125], dextrans of 
different molecular weights [123, 126, 127], bovine serum albumin [123, 126, 127] and egg 
proteins [128], and all these were able to be transferred from neonatal (24 h) intestines into 
blood stream.  This leads to the accepted concept that protein absorption by neonatal pigs is 
a non-selective process [122, 129].  In addition, it has been shown that the efficiency of 
absorption negatively correlates with molecular size [127]. 
This non-selective absorption of macromolecules drops significantly at about 24 h after 
birth [123, 127].  The cessation of macromolecular transfer after this time frame is referred 
to as gut closure.  The mechanism of gut closure is not well understood.  The fetal type of 
porcine enterocytes are able to endocytose macromolecules non-selectively from intestinal 
lumen [122].  At 6 days postnatally, mature enterocytes, which have much lower 
endocytotic activity, start to replace fetal enterocytes.  This replacement is complete at about 
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6 weeks after birth [123, 130].  Therefore, during the first 6 days of life, the neonatal 
porcine enterocytes maintain the ability for non-selective endocytosis.  Since gut closure 
happens at about 24-36h, prior to the enterocyte replacement, the cessation of absorption 
must be explained by other mechanisms. 
Little is known about the intracellular processing of proteins in relationship to gut 
closure.  Since intracellular proteolytic activity of capthepsin B and D was found to be 
similar in newborn and 6-day old piglets, Ekstrom hypothesized that gut closure is not due to 
increased intracellular degradation of the endocytosed proteins, but is most likely related to a 
decrease in exocytosis [123].  This hypothesis has yet to be tested. 
Three aspects of intestinal protein absorption after gut closure need to be mentioned:  1) 
micromolecules (molecular weight less than a few kDa) can be absorbed independent of gut 
closure [127]; 2) a small amount of macromolecules can be transferred to blood after gut 
closure [127]; and 3) certain proteins can be selectively absorbed from intestinal lumen into 
blood by a receptor mediated process termed specific protein absorption. 
1.4.2. Selective intestinal protein absorption in piglets 
As mentioned above, the absorption of macromolecules, including immunoglobulin, by 
neonatal piglets has been thought to be primarily non-selective; however, an increasing body 
of evidence indicates that in addition to the non-selective absorption of proteins through 
“leaky” epithelium of neonatal intestine, there is also receptor-mediated absorption of some 
proteins such as lactoferrin and insulin-like growth factor-I, and also of immunoglobulin. 
1.4.2.1. Immunoglobulin 
The absorption of colostral immunoglobulin by newborn pigs is well documented and 
has been long regarded as non-selective endocytosis.  The results of the recent studies, 
however, suggest that the immunoglobulin absorption may also involve selective mechanisms: 
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first, the intestinal transfer of immunoglobulin exceeds that of other macromolecules [131]; 
further, the efficiency of absorption of porcine IgG by neonatal piglets is higher than that of 
bovine IgG [132].  Thus, Sangild suggested that the endocytosis of immunoglobulins by 
neonatal enterocytes is a highly specific process [1].  In enterocytes of rodents, an 
immunoglobulin Fc receptor has been identified and is responsible for the transport of 
immunoglobulin [133, 134].  Recently, the immunoglobulin Fc receptor has also been 
identified and characterized in pigs [135].  The same study showed that 4-week-old pigs are 
still able to absorb bovine IgG, despite that gut closure occurs much earlier, which made the 
possibility of non-selective mechanism unlikely.  It is possible that non-selective and 
selective intestinal absorption of immunoglobulins occur together in pre-closure piglets. 
1.4.2.2. Lactoferrin (LF) 
Lactoferrin is a major ion-binding protein in porcine milk and its antimicrobial activities 
have been well documented.  The fact that oral administration of bovine lactoferrin protects 
pigs from endotoxic shock indicates that lactoferrin can be absorbed into the blood stream 
[93].  The absorption of bovine lactoferrin by neonatal pigs has been investigated by Harada 
and his research group [124, 136-138], who demonstrated that bovine lactoferrin was 
absorbed from the gut into blood.  Enterohepatic recycling of lactoferrin as well as transfer 
of lactoferrin from plasma to cerebrospinal fluid were also shown [124, 137].  Further, 
absorption of bovine lactoferrin was demonstrated in growing pigs (10-12 weeks old) [139]. 
The observation that growing pigs can absorb lactoferrin after gut closure points to a 
selective mechanism of absorption.  Indeed, the presence of lactoferrin receptors on 
enterocytes of several species has been reported and extensively reviewed [140, 141].  The 
initial investigation of porcine intestinal lactoferrin receptor by Gislason confirmed the 
presence of lactoferrin receptors on porcine enterocytes, the density of which was 
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age-independent [142, 143].  In 2007, the cDNA of the porcine homologue of human 
lactoferrin receptor was cloned.  The molecular weight of the receptor protein was 35 kDa 
under reducing conditions and ~135 kDa under non-reducing conditions, suggesting that the 
porcine lactoferrin receptor is a tetramer [144].  The physiological role of this receptor 
needs further investigation. 
1.4.2.3. Insulin-like growth factor I (IGF-I) 
Insulin-like growth factor I (IGF-I), a 7.5 kDa protein present in porcine colostrum and 
milk [145], stimulates cellular proliferation and differentiation.  The absorption of IGF-I by 
neonatal piglets is independent of gut closure [146], and an IGF-I receptor in porcine small 
intestine has been identified [147], strongly suggesting that IGF-I absorption is 
receptor-mediated. 
1.5. Plasma protein profiles in pigs 
The plasma protein profiles in neonatal pigs are poorly characterized.  Several studies 
have investigated the developmental changes of major porcine plasma proteins, such as 
albumin, α-fetoprotein, α1-antitrypsin, α1-acid glycoprotein, fetuin, transferrin and 
immunoglobulin, in porcine fetuses and neonates [148-150].  Recently, the serum and 
plasma protein profiles of 4 months old pigs have been studied [151].  Thirty-nine proteins 
were identified in that study, including most of those previously reported as major proteins in 
neonatal porcine plasma, except α-fetoprotein [151].  The concentration of α-fetoprotein has 
been reported to drop below detectable level at one month of age [148].  Other studies 
investigating porcine plasma proteins have focused on characterization of the acute phase 
protein changes, e.g., C-reactive protein, haptoglobin and pig major acute phase protein [148, 
152].  Otherwise there is little information on changes of plasma protein profiles in piglets 
pre- and post- suckling to determine which proteins are absorbed or up-regulated after 
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suckling.
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2. Rationale, hypotheses and objectives 
2.1. Experiment 1 
2.1.1. Rationale 1 
It has been demonstrated that porcine milk fat globule membrane (MFGM) is a binding 
target of F4 E. coli [153], and that porcine milk MFGM is able to inhibit the binding of F4 
fimbriae to porcine intestinal brush border membrane [154].  Many proteins have been 
identified on MFGM from human, murine and bovine milk.  A previous study in our 
laboratory have demonstrated that two major MFGM proteins in porcine milk, namely, 
porcine lactadherin and heart fatty acid binding protein, interact with F4ac-fimbria [3]. The 
potential interaction of the other MFGM proteins with F4 fimbria has not been investigated. 
2.1.2. Hypothesis 1 
There are several milk fat globule membrane proteins that bind F4ac-fimbria. 
2.1.3. Objective 1 
To visualize milk fat globule membrane proteins that can interact with F4ac-fimbria by 
2D Overlay Western blot and to identify them by LCMS/MS. 
2.2. Experiment 2 
2.2.1. Rationale 2 
Many non-immunoglobulin proteins with potential defense function have been identified 
in porcine milk [2-4].  One of these proteins, namely, porcine lactoferrin can be absorbed 
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into the circulation to function systemically and protect against septicemia [124, 137-139].  
Neonatal pigs are assumed to non-selectively absorb many proteins and macromolecules 
from the gut into the blood stream, suggesting that many colostral proteins can be absorbed 
before 24~36h of life.  However, there are limited studies demonstrating unequivocally the 
identity of porcine milk proteins that can be absorbed by neonatal piglets. 
2.2.2. Hypothesis 2 
Numerous porcine colostral proteins can be absorbed from the intestine of neonatal 
piglets into the blood during the first 24 h of life. 
2.2.3. Objective 2 
To identify absorbable non-immunoglobulin porcine colostral proteins by comparison of 
plasma protein profiles of neonatal piglets before and after suckling. 
 26
 
 
 
 
3. F4ac-fimbrial-binding proteins on porcine milk fat globule membrane (MFGM) 
3.1. Introduction 
F4-positive enterotoxigenic E. coli (ETEC) is the most commonly encountered 
diarrheagenic pathogen in neonatal piglets in the modern swine industry.  The attachment of 
ETEC fimbriae to specific glycoprotein and glycolipid receptors on the intestinal mucosa is a 
necessary initial step in the pathogenesis of enterotoxigenic colibacillosis.  Prevention of 
bacterial attachment to the intestinal mucosa is the most effective defense against ETEC.  
Accordingly, colostral anti-F4 antibodies induced by previous exposure or vaccination of the 
sows effectively prevent neonatal diarrhea caused by F4-positive ETEC.  Many studies have 
demonstrated additionally that colostrum and milk contain non-immunoglobulin components 
that decrease or prevent attachment of pathogenic bacteria in vitro [3, 11, 154].  Atroshi et al. 
demonstrated that F4-positive E. coli bind to sow milk fat globule membranes (MFGM) [153] 
and Choi et al. reported that MFGM inhibited binding of the F4 fimbria to the intestinal brush 
border [154].  Neither of these studies, however, identified the specific individual 
components of porcine MFGM involved in the binding of F4. 
Milk fat droplets are surrounded by a membrane which originates from the apical cell 
membrane of the mammary glandular epithelium [23].  This membrane is called MFGM and 
it contains several major and minor proteins [6, 26, 77-79, 155, 156].  MFGM proteomic 
profiles have been defined for human [78], bovine [79] and murine [5] milk.  Several 
MFGM proteins in milk were reported to be associated with host defense.  Both lactadherin 
and mucin in human MFGM have anti-rotaviral activity [61, 62].  Human mucin inhibits 
adhesion of S-fimbriated E. coli to buccal epithelium [11], aggregates poxvirus [13] and 
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inhibits infection of human T lymphoblastoid cells with HIV-1 [14].  These in vitro studies 
suggest that MFGM proteins may play an important defensive role in the protection of 
mammalian neonates of various species from infectious diseases. 
The porcine MFGM proteomic profile has not been defined and little is known about the 
function of porcine MFGM proteins.  Previously, we employed affinity chromatography and 
isolated several F4-fimbrial-binding proteins from porcine skim milk [3], two of which, 
namely lactadherin and heart fatty acid binding protein, have been reported to be major 
MFGM proteins in several species [6].  We also demonstrated that lactadherin interfered 
with attachment of F4-positive ETEC to porcine small intestinal villi ex vivo [3].  
Accordingly, it is possible that milk components that bind to F4-fimbriae may act as receptor 
analogues and interfere with the binding of F4-positive ETEC to the intestinal surface [11, 
157, 158].  
The purpose of this study was to investigate the ability of porcine MFGM proteins to 
interact with F4ac in vitro and to characterize protein profiles of porcine MFGM by liquid 
chromatography/mass spectrometry (LC MS/MS). 
3.2. Materials and methods 
3.2.1. Isolation of porcine milk fat globule membrane (MFGM) 
Porcine milk was obtained from healthy sows 21 d after farrowing (Prairie Swine Centre 
Inc., Saskatoon, SK, Canada) in a previous study [3]: after subcutaneous administration of 2 
ml of oxytocin (MTC Pharmaceuticals, Cambridge, ON, Canada), the milk was expressed 
manually and kept at 4°C during transportation to the laboratory.  The milk fat was obtained 
by centrifugation at 3600 x g for 15 minutes (min) at 4°C, the skim milk was removed and 
the fat fraction was pooled and stored at –70°C.  MFGM was isolated from porcine milk fat 
according to a previously published protocol [26, 159].  Briefly, the milk fat was washed 
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three times with PBS (1.6 mM NaH2PO4, 9.4 mM Na2HPO4, 154 mM NaCl, pH=7.2) and 
centrifuged at 2000 x g for 15 min at 20ºC.  The supernatant creamy layer was collected, 
resuspended in PBS, and subjected to intensive sonication (6 x 60 sec with cooling intervals 
on ice) to break and release MFGM which was harvested by ultracentrifugation at 100,000 x 
g for 90 min at 4ºC.  The MFGM pellet was resuspended in double-distilled (dd)H2O and 
the protein concentration of MFGM proteins was adjusted to 5 mg/ml ddH2O, based on the 
volumes obtained, using a Bio-Rad protein assay kit (Bio-Rad Laboratories, Hercules, CA, 
USA) with a bovine serum albumin (BSA) standard. 
3.2.2. Purification of F4 fimbriae 
F4ac was prepared in a previous study and kindly provided by Dr. Shahriar [2].  F4ac 
were isolated from F4ac-positive ETEC according to a published method [160] and further 
purified by gel filtration chromatography using a Superdex 75 column (Amersham 
Biosciences, Uppsala, Sweden) as described previously [2].  The purity of F4ac was 
determined to be about 95% by semi-quantitative densitometry [2]. 
3.2.3. Electrophoresis 
3.2.3.1. One-dimensional SDS-PAGE 
One-dimensional (1D) sodium dodecyl sulfate (SDS) polyacrylamide gel (12%, 
discontinuous) electrophoresis (PAGE) was performed under reduced conditions using 
glycine buffer system according to the instructions of the PAGE equipment manufacturer 
(Mini-PROTEAN® 3 Cell, Bio-Rad Laboratories, Mississauga, ON, Canada). 
3.2.3.2. Two-dimensional SDS-PAGE 
Isolated MFGM proteins were subjected to isoelectric focusing in linear immobilized pH 
gradient strips (IPG) (Immobiline Dry Strip, pH 3–10, 13 cm, GE Healthcare Bio-Sciences 
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AB, Uppsala, Sweden) using an isoelectric focusing system (IPGphor; GE Healthcare 
Bio-Sciences AB, Uppsala, Sweden) [2], and subsequently separated based on MW using a 
large electrophoretic system (PROTEAN® II xi Cell, Bio-Rad Laboratories, Mississauga, ON, 
Canada) as previously described [161].  Approximately 500 µg protein was loaded per gel 
for colloidal Coomassie G-250 stain [162] and 25 µg for gels used for 2D Overlay Western 
Blot. 
3.2.4. Overlay Western Blot 
Overlay Western Blot was used to investigate the interaction between the isolated 
MFGM proteins and purified F4-fimbriae.  The isolated MFGM proteins separated by 1D 
and 2D SDS-PAGE were electro-blotted on to polyvinylidene fluoride (PVDF) membranes 
using a small (for 1D PAGE) or a large (for 2D PAGE) electrophoretic transfer cell apparatus 
(Bio-Rad Laboratories, Mississauga, ON, Canada) and Overlay Western Blot detection of 
F4-binding proteins was performed as described previously [120].  Briefly, 25 µg of MFGM 
proteins were separated by 2D SDS-PAGE and blotted to the PVDF membrane which was 
subjected sequentially to the following procedures: blocking of any remaining protein 
binding sites with blocking buffer (2% non-fat dry milk and 0.1% Tween-20 in PBS) at 4ºC 
overnight; incubation with 2 µg/ml purified F4ac in blocking buffer with gentle shaking for 
90 min at room temperature; three 15-min washes with PBS-Tween-20 (PBST) buffer (0.1% 
Tween-20 in PBS); incubation with primary rabbit anti-F4 polyclonal serum (Dr. J. M. 
Fairbrother, Faculté de Médecine Vétérinaire, Université de Montréal, Saint-Hyacinthe, QC, 
Canada) in blocking buffer (1:2000) for 90 min at room temperature; three 15 min washes in 
PBST; incubation with secondary goat anti-rabbit IgG alkaline phosphatase conjugate (Sigma 
Chemical Co, St Louis, MO, USA) in blocking buffer (1:20,000) for 90 min at room 
temperature; three 15-min washes in PBST, and exposure to a substrate solution (Immun-Star 
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Substrate, Bio-Rad Laboratories, Mississauga, ON, Canada).  Chemiluminescent signals 
demonstrating F4ac-binding proteins was detected by exposure of the PVDF membrane to an 
X-ray film (Eastman Kodak Company, Rochester, NY, USA) which was developed in an 
automated X-ray developer (Kodak, M35AX-OMAT processor, NY, USA). 
One-dimensional Overlay Western Blot was used initially in a pilot study to determine if 
any MFGM proteins interact with F4ac, and to demonstrate the presence of interaction with 
porcine lactadherin used as a positive control and the absence of interaction with BSA used as 
a negative control.  In addition, omission of incubation with F4ac for both 1D and 2D 
Overlay Western Blots was employed to demonstrate any non-specific binding between 
primary or secondary antibodies to blotted MFGM proteins.  We also carried out both 1D 
and 2D Overlay Western Blot experiments using protein-free blocking buffer (Pierce, 
Rockford, IL, USA) instead of skim milk to rule out potential interaction between F4ac and 
skim milk proteins in blocking buffer, and we obtained similar results. 
3.2.5. Protein identification 
Porcine MFGM protein spots in 2D SDS-PAGE gels were excised manually by pipet 
tips, transferred into 0.5 ml Eppendorf tubes and submitted for liquid chromatography mass 
spectrometry/mass spectrometry (LC MS/MS) identification, performed by the National 
Research Council’s Plant Biotechnology Institute (Saskatoon, SK, Canada).  The spots were 
placed in a 96-well microtiter plate and were digested in gel using a MassPREP station 
robotic protein handling system Waters/Micromass (Milford, MA, USA) following the 
standard digestion protocol.  The digested samples were evaporated to dryness, then 
dissolved in 15 µl of 1% aqueous trifluoroacetic acid, of which 3 µl was injected on to a 
NanoAcquity UPLC (Waters, Milford, MA, USA) interfaced to a Q-Tof Ultima Global hybrid 
tandem mass spectrometer fitted with a Z-spray nanoelectrospray ion source 
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(Waters/Micromass, Manchester, UK).  The digested peptide sample was loaded onto a C18 
trapping column (Symmetry 180 µm X 20 mm; Waters, Milford, MA, USA) and washed for 
3 min using solvent A (0.1% formic acid in H2O) at a flow rate of 15 μL/min.  The trapped 
peptides were eluted onto a C18 analytical column (1.7 µm BEH130 C18 100 µm X 100 mm; 
Waters, Milford, MA, USA).  Separations were performed using a linear solvent gradient of 
10:95% to 45:55% (solvent A:solvent B [0.1% formic acid in acetonitrile]) over 45 min.  
The composition was then changed to 20:80% (A:B) and held for 10 min to flush the column 
before re-equilibrating for 7 min at 100:0% (A:B).  Mass calibration of the Q-TOF 
instrument was performed using a product ion spectrum of Glu-fibrinopeptide B acquired 
over the m/z range 50 to 1900.  LC MS/MS analysis was carried out using data-dependent 
acquisition, during which peptide precursor ions were detected by scanning from m/z 400 to 
1900 in TOF MS mode.  Multiply-charged ions (2+, 3+, or 4+) rising above predetermined 
threshold intensity are automatically selected for TOF MS/MS analysis, by directing these 
ions into the collision cell where they fragment using low energy CID by collisions with 
argon, and varying the collision energy by charge state recognition, product ion spectra are 
acquired over the m/z range 50 to 1900.  LC MS/MS data was processed using Mascot 
Distiller (ver. 2.1.1.0, Matrixscience) and searched against the NCBInr or Swiss-Prot 
databases using MASCOT (Matrix Science Inc., Boston, MA).  Searches were performed 
using carbamidomethylation of cysteine as a fixed modification and oxidation of methionine 
as a variable modification, allowing for one missed cleavage during trypsin digestion.  In 
this study, those proteins with at least 2 matched peptides are considered to be successfully 
identified (personal communication with Doug Olson [National Research Council’s Plant 
Biotechnology Institute, Saskatoon, SK, Canada]).  In the search results, a protein score and 
a score threshold is given to each protein.  Protein scores greater than the threshold are 
considered to be significant.  In some cases, more than one protein is identified from the 
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same spot.  These proteins will all be listed and the one that has the highest score is called 
“first hit”. 
3.3. Results 
Isolated porcine MFGM proteins were separated by 1D and 2D SDS-PAGE and 
visualized by Coomassie stains (Figure 3.1 and 3.2A, respectively).  The major protein 
bands/spots observed in Coomassie stained 2D gel were submitted for LC MS/MS 
identification (Table 3.1) and in total, 17 distinct porcine MFGM proteins were identified 
(Table 3.2).  Purified F4ac fimbriae (Figure 3.3) were used in 1D and 2D Overlay Western 
Blot for detection of interacting MFGM proteins (Figure 3.1 and 3.2B).  Four bands (~ 
66kDa, 47kDa, 44kDa and 31kDa) and several spots were detected by 1D and 2D Overlay 
Western Blot, respectively (Figure 3.1 and 3.2B).  In the 1D experiment, porcine lactadherin, 
used as a positive control, was positive; while BSA, used as a negative control, was negative 
(Figure 3.1).  By omission of F4ac, both the 1D and 2D assays showed no positive signals 
(Figure 3.1 and 3.2C).  Comparative matching of MW and isoelectric points (pI) of the 
detected F4ac-fimbrial-binding spots with the previously identified MFGM proteins in 
Coomassie stained 2D gels (Figure 3.2A and B) revealed that lactadherin, butyrophilin, 
adipophilin, and acyl-CoA synthetase 3 gave strong F4ac-fimbrial-binding signals in vitro. 
3.4. Discussion 
Using 2D SDS-PAGE protein separation and LC MS/MS identification, 17 proteins 
were identified in porcine MFGM.  Lactadherin, butyrophilin, adipophilin, and acyl-CoA 
synthetase 3 were demonstrated and identified by Overlay Western Blot and LC MS/MS, 
respectively, to interact with F4ac purified from clinically relevant F4 positive 
enterotoxigenic E. coli. 
MFGM proteins are comprised of 8 major proteins according to previous reports in 
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several species [5, 6, 26, 79], namely, xanthine dehydrogenase, butyrophilin, lactadherin, 
adipophilin and fatty acid binding protein, mucin 1, mucin 15 (previous known as PAS III 
[27]) and CD36.  Consistent with the previous reports [5, 26, 78, 156], only the first five of 
these 8 could be separated by 2D SDS-PAGE and visualized; whereas, the last three (i.e. 
mucin 1, mucin 15 and CD36) were not visualized and identified in this study.  Accordingly, 
the overall two-dimensional electrophoretic pattern of porcine MFGM in this study is similar 
to previously reported human [78], bovine [26] and murine [5] MFGM patterns.  In addition, 
butyrophilin, adipophilin and lactadherin were also identified or co-identified from multiple 
minor spots in our 2D SDS-PAGE gel (Table 3.2), but these minor spots have smaller MW 
than those of butyrophilin, adipophilin and lactadherin.  These findings are unexpected; the 
LC MS/MS data is however convincing and accordingly, we suspect that these minor spots 
may be, or may contain, fragments of the native (parent) proteins.  These fragments may not 
be present naturally in the porcine MFGM; instead, they may be generated during sample 
processing (i.e. sample degradation). 
By Overlay Western Blot technique, several spots were demonstrated to interact with 
F4ac.  In the 1D experiment, F4ac interacted with the positive control, porcine lactadherin, 
while it did not react with the negative control, BSA.  Further, when F4ac was omitted, both 
1D and 2D experiments demonstrated no positive signals.  Taking all together, we believed 
that Overlay Western Blot in this study reliably demonstrated the in vitro interactions between 
F4ac and porcine MFGM proteins.   
The interaction of lactadherin with F4ac-fimbriae, detected by Overlay Western Blot in 
this study, agrees with our previous study in which lactadherin was isolated from porcine 
skim milk by F4ac-fimbrial affinity chromatography and demonstrated to inhibit the 
attachment of F4ac positive E. coli to intestinal villi ex vivo [3].  In addition to lactadherin, 
butyrophilin, adipophilin and acyl-CoA synthetase 3 all were demonstrated in this study to 
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give strong F4ac-fimrial-binding signals (Figure 3.2B). 
Adipophilin, previously called adipose differentiation-related protein, has a similar MW 
(47 kDa) and pI (~ 6-7) to lactadherin, and was thus overlooked for a long time [6] due to the 
similar electrophoretic migration of these two proteins.  Adipophilin is located on the 
surface of lipid droplets and it is thought to be involved in lipid storage [22, 69].  Based on a 
crude comparison with previously published 2D SDS-PAGE images of human [78], murine 
[5] and bovine [26] MFGM proteins, it seems that adipophilin is more abundant in porcine 
MFGM. 
The 31 kDa positive band in 1D Overlay Western Blot is composed of several spots in 
the 2D Overlay Western Blot.  One (Figure 3.2B: MW ~ 31 kDa, pI ~ 5.1) of the strongest 
positive signals was identified as acyl-CoA synthetase 3 (ACS3).  ACS3 is related to lipid 
metabolism and is highly expressed in the brain [163].  Several ACSs, including ACS3, have 
recently been identified in bovine MFGM recently [80].  Even though ACS3 has a relatively 
low abundance compared to the other major porcine MFGM proteins (Figure 3.2A), it 
generated a strong detection signal with F4ac fimbria in Overlay Western Blot (Figure 3.2B), 
indicating potential high affinity of porcine ACS3 to F4ac fimbria.  Two other strong 
positive signals (Figure 3.2B: MW ~ 28 kDa, pI ~ 7.4; and MW ~ 28 kDa, pI ~ 8) in the same 
MW area were not detected in Coomassie-stained 2D SDS-PAGE (Figure 3.2A), thus were 
not possible to be indentified in this study; however, these proteins may be biologically 
important. 
A positive band at ~ 66 kDa in 1D and 2D Overlay Western Blot has similar 
electrophoretic migration pattern as the monomer of butyrophilin (65-67 kDa) [5, 6, 164]; 
however, we failed to identify this protein by LC MS/MS.  A protein band, identified by LC 
MS/MS as butyrophilin, located in high molecular weight region of 2D SDS-PAGE reacted 
strongly with F4ac fimbria (Figure 3.2B).  An unexplained aggregation of butyrophilin has 
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been previously reported in 2D but not 1D SDS-PAGE [164] and was observed also in this 
study.  Butyrophilin is the major structural and most abundant protein on bovine MFGM [6, 
43].  Butyrophilin is a member of the immunoglobulin (Ig) superfamily, a broad family 
which is characterized by the presence of Ig-like folds and includes various proteins that 
serve as receptors and immune regulators [165].  A recent study demonstrated that the 
receptor for the subgroup C avian sarcoma and leukosis viruses was similar to mammalian 
butyrophilin [52].  Nevertheless, the most commonly reported function of butyrophilin is the 
control of milk fat secretion [6, 22, 24, 47], and little is known about any potential role as a 
receptor in mammalian species. 
It should be noted that in addition to those spots that interacted strongly with F4ac 
fimbriae, several spots reacted weakly with F4ac.  One of these is fatty acid binding protein 
(spot group 36, Figure 3.2A), and this agrees with the previously reported affinity of fatty 
acid binding protein to F4ac fimbria [3]. 
Binding interaction between porcine MFGM and F4 (K88) positive E. coli [153] and 
inhibition of E. coli attachment to porcine small intestinal brush border [154] were previously 
demonstrated.  In this study, interaction between F4ac fimbria and lactadherin, butyrophilin, 
adipophilin, and acyl-CoA synthetase 3 was demonstrated.  It is possible that these proteins 
serve as receptor analogues for F4ac fimbria and may prevent attachment of E. coli to 
intestinal epithelium ex vivo as demonstrated previously [3, 154]. 
 36
 
Figure 3.1. One dimensional (1D) SDS-PAGE (lanes 1-3) and 1D Overlay Western Blot using 
purified F4ac as a probe (lanes 4-6).  Porcine MFGM proteins (lane 1), bovine serum 
albumin (BSA) (lane 2) and purified porcine lactadherin (lane 3) were subjected to 
electrophoresis and stained by Coomassie.  The proteins were transferred to PDVF 
membrane and probed with purified F4ac.  Using a chemiluminescent method, 4 positive 
bands (arrow heads, from top to bottom, ~ 66kDa, 47kDa, 44kDa and 31kDa) from porcine 
MFGM (lane 4) were detected.  The negative control, BSA, (lane 5) did not react, while 
porcine lactadherin used as a positive control (lane 6) reacted with F4ac fimbriae.  When 
F4ac was omitted, none of the samples showed positive signals (7: porcine MFGM; 8: BSA; 
9: porcine lactadherin) 
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Figure 3.2. Coomassie-stained two dimensional (2D) SDS-PAGE (A) and 2D Overlay 
Western Blot (B) of porcine MFGM proteins using purified F4ac as a probe.  Major 
F4ac-fimbrial-binding spots (closed ovals) and other protein spots (closed squares) are 
indicated on the SDS-PAGE (A).  Several spots (dashed ovals and squares) were visible by 
Coomassie stain, but failed to be identified by LC MS/MS.  Some of these spots reacted 
with F4ac (dashed ovals) while others (dashed squares) did not.  When F4ac was omitted, 
none of the MFGM proteins showed positive signals (C).  The numbers correspond to those 
in Table 3.1 and Table 3.2.
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Figure 3.3. Coomassie-stained 1D SDS-PAGE of purified F4ac fimbria.  A prominent band 
at ~ 27 kDa is demonstrated. 
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Mammalian neonates are protected against infectious diseases by a myriad of protective 
substances present in ingested colostrum and milk.  Neonatal local and systemic protection 
by colostral and milk immunoglobulins is well characterized and indisputable.  In addition, 
some other substances in porcine colostrum/milk have been demonstrated to have potential 
protective effects (e.g. LPS-binding proteins, F4-fimbrial-binding proteins and bactericidal 
peptides).  However, only few (e.g. lactoferrin) have been reported to be absorbed by piglets 
from the gut into blood and to potentially exhibit protection against systemic diseases.  
Since protein absorption by neonatal piglets has been assumed to be non-selective, it is 
reasonable to hypothesize that other non-immunoglobulin colostral proteins can be absorbed 
and are involved in systemic protection of neonates.  Accordingly, experiments presented in 
the following chapter were designed to compare plasma protein profiles of piglets before and 
after suckling to characterize absorption of colostral proteins by piglets. 
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4. Plasma protein profiles of neonatal pigs before and after suckling 
4.1. Introduction 
The epitheliochorial placentation of pigs and several other domestic animals prevents 
the transfer of maternal plasma macromolecules from dam to fetus in utero.  Thus, piglets 
are born hypogammaglobulinemic and maternal immunoglobulins are absorbed from the 
intestine into the systemic circulation from colostrum ingested within the first 24 to 36 hours 
after birth.  The importance of absorption of colostral immunoglobulins for neonatal 
protection against disease is well characterized and considered indisputable [166].   
In addition to immunoglobulins, colostrum contains a myriad of substances 
potentially involved in various aspects of neonatal development and immune defense [2, 61, 
93]; however, neonatal absorption of intact colostral components other than immunoglobulins 
is poorly characterized.  Reports have documented the ability of neonatal piglets to absorb a 
variety of substances from the gastrointestinal tract to the systemic circulation within 24 to 36 
hours after birth, e.g., bovine IgG [123], porcine IgG [124, 125], dextrans of different 
molecular weights [123, 126, 127], bovine serum albumin [123, 126, 127], egg proteins [128], 
lactoferrin [137] and insulin-like growth factor I [146].  It has also been shown that the 
degree of absorption negatively correlates with molecular size [127].  Accordingly, early 
post-natal protein absorption by neonatal piglets was inferred to be non-selective [122].  The 
magnitude of the non-selective absorption of macromolecules drops significantly at about 24 
h after birth [123, 127].  This sudden decrease and cessation of macromolecular transfer is 
referred to as gut closure.  While the mechanism of gut closure is not well understood, it is 
assumed that after gut closure only limited selective absorption of macromolecules takes 
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place in the gastrointestinal tract. 
Based on the concept that proteins can be non-selectively absorbed by neonatal piglets 
before gut closure, and the fact that neonatal digestive enzymes have low activity [167], it 
may be reasonably assumed that many intact proteins are absorbed from ingested colostrum 
into the blood stream by neonatal piglets; however, unequivocal supporting experimental 
evidence is limited.  Harada et al. used two-dimensional sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (2D SDS-PAGE) to investigate pre- and post-suckling 
plasma protein profile changes in neonatal piglets and reported that 2D SDS-PAGE of plasma 
from post-suckling piglets demonstrated ~ 30 more protein spots than plasma from 
pre-suckling piglets; however, the identity of these proteins was not determined [124].  
Based on the well characterized absorption of colostral immunoglobulins, it is clear that a 
substantial portion of the protein spots identified by Harada et al. in post-suckling plasma 
correspond to immunoglobulins.  It is possible, however, that the increase in protein spots in 
post-suckling plasma is also in part due to absorption of non-immunoglobulin colostral 
proteins and/or up-regulation of plasma protein synthesis induced by suckling. 
The objectives of this study were to characterize the major proteins in porcine neonatal 
plasma and to determine the changes that occur in plasma protein profiles, including those of 
minor proteins, in piglets after natural suckling. 
4.2. Materials and methods 
4.2.1. Experimental design 
To determine the changes of plasma protein profiles before and after natural suckling of 
neonatal piglets, the plasma of 9 piglets from 3 sows (3 piglets/sow) was studied by 2D 
SDS-PAGE.  Blood samples were collected from the anterior vena cava into tubes 
containing sodium citrate right after the birth and again at 24 hours after suckling the dam.  
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The whole plasma and the plasma with immunoglobulins removed, termed 
immunoglobulin-removed plasma in this study, were subjected to 2D SDS-PAGE.  
Electrophoretic patterns of paired plasma samples pre- and post- suckling, with and without 
immunoglobulin removal were compared.  Prominently increased proteins after suckling 
were defined in this study as protein spots that were absent before and present after suckling, 
or protein spots with low concentration before suckling and obvious increased concentration 
after suckling, determined by visual comparison of staining intensity.  The proteins that 
increased prominently after suckling and the major plasma proteins were identified by mass 
spectrometry (MS) and liquid chromatography mass spectrometry/mass spectrometry (LC 
MS/MS). 
4.2.2. Separation of plasma 
Blood samples (~ 1.5-2 ml) were collected into 4 ml tubes containing 0.25 ml of 
buffered 0.105 M sodium citrate solution as an anti-coagulant, and then stored on ice for less 
than 8 hours before separation of plasma.  Plasma samples were obtained by centrifugation 
of the whole blood at 2000 x g at 4ºC for 15 minutes and stored at -20ºC. 
4.2.3. Removal of immunoglobulins 
In order to increase the visibility of minor plasma proteins on SDS-PAGE, affinity 
chromatography was employed to remove immunoglobulins from the plasma.  
Approximately 7 ml of protein-A sepharose medium was packed in the column according to 
manufacturer’s instruction (GE Healthcare Bio-Science AB, Uppsala, Sweden).  Plasma 
(100 μl) was diluted with double distilled (dd) H2O to a final volume of 1 ml and filtered 
through a 0.45 μm syringe filter (Whatman Inc, Clifton, NJ, USA).  The column was 
equilibrated with 3 column volumes (CV) of buffer A (PBS, 1.6 mM NaH2PO4, 9.4 mM 
Na2HPO4, 154 mM NaCl, pH=7.2) at a speed of 1 ml/minute.  Next the diluted plasma 
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samples were injected by a sample loop at a speed of 0.5 ml/minute.  The unbound proteins 
were washed out by 3 CV of buffer A at a speed of 0.5 ml/minute and collected.  This 
washed out fraction is the immunoglobulin-removed plasma and contained plasma proteins 
with majority of the immunoglobulins removed.  Immunoglobulins were eluted by 3 CV of 
buffer B (0.1 M glycine, pH 3), separated by 1D and 2D SDS-PAGE and visualized by 
colloidal Coomassie G-250 (Appendix A).  The whole process was performed in AKTA 
Purifier 10 (Amersham Biosciences, Uppsala, Sweden) and controlled by software 
UNICORN 5.11 (GE Healthcare Bio-Science AB, Uppsala, Sweden).  The 
immunoglobulin-removed plasma samples were dialysed against distilled H2O for 72 hours, 
frozen at -20ºC and subsequently lyophilized in Free Zone Plus freeze dry system (Labconco 
Corp., Kansas City, MO, USA).  The lyophilized proteins were resuspended in ddH2O and 
adjusted to the final concentration of 3 μg/μl determined by Bio-Rad protein assay kit 
(Bio-Rad Laboratories, Hercules, CA, USA) using bovine serum albumin (BSA) as a 
standard. 
4.2.4. Two dimensional SDS-PAGE 
The whole plasma samples (25 μl) were subjected to isoelectric focusing in linear 
immobilized pH gradient strips (IPG) (Immobiline Dry Strip, pH 3–10, 13 cm, GE Healthcare 
Bio-Sciences AB, Uppsala, Sweden) using an isoelectric focusing system (IPGphor; GE 
Healthcare Bio-Sciences AB, Uppsala, Sweden) [2] and subsequently separated based on 
molecular weight using a large electrophoretic system (PROTEAN® II xi Cell, Bio-Rad 
Laboratories, Mississauga, ON, Canada) as previously described [161].  Proteins of whole 
plasma separated by 2D SDS-PAGE (9 pairs of gels, 3 pairs per litter, 18 gels in total) were 
visualized by Coomassie R-250 stain.  
Resuspended immunoglobulin-removed plasma samples (16.7 ml) containing 3 μg/μl 
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protein (~ 50 μg) were subjected to 2D SDS-PAGE (9 pairs of gels, 3 pairs per litter, 18 gels 
in total) and visualized by silver stain (data not presented).  To obtain sufficient amount of 
proteins suitable for LC MS/MS identification, equal amounts (120 μg) of 
immunoglobulin-removed plasma from each of the three littermates, before and after suckling, 
respectively, were pooled and lyophilized.  The pooled samples were prepared for each litter.  
Subsequently, 360 μg of pooled proteins from the pre- and post-suckling 
immunoglobulin-removed plasma samples were subjected to 2D SDS-PAGE (3 pairs of gels, 
1 pair per litter, 6 gels in total) and visualized by colloidal Coomassie G-250 stain [162].  
The silver-stained pattern of the 18 individual 2D SDS-PAGE gels of 
immunoglobulin-removed plasma samples pre- and post-suckling were very similar to the 6 
colloidal Coomassie G-250 stained gels of pooled littermate immunoglobulin-removed 
plasma protein samples before or after suckling.   
The detection limit of Coomassie R-250 is ~ 50 ng according to the manufacturer 
(Bio-Rad Laboratories, Hercules, CA, USA), that of colloidal Coomassie G-250 stain was 
reported to be ~ 1 ng protein [162] and that of silver stain is ~ 0.1 ng [168]. (See Appendix B 
for sensitivities of detection in our laboratory) 
4.2.5. Protein identification 
Proteins increased prominently after suckling and the major proteins in neonatal porcine 
plasma were excised manually from the Coomassie stained gels, transferred to 0.5 ml 
Eppendorf tubes and submitted for identification by mass spectrometry (MS) or liquid 
chromatography mass spectrometry/mass spectrometry (LC MS/MS) performed by the 
National Research Council’s Plant Biotechnology Institute (Saskatoon, SK, Canada).  All 
samples were first subjected to MS analysis.  Samples that failed to be identified by MS 
were then subjected to LC MS/MS.  Briefly, selected spots were placed in a 96 well 
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microtiter plate and digested using a MassPREP station robotic protein handling system 
Waters/Micromass (Milford, MA, USA), following the standard digestion protocol. 
For MS, Peptide Mass Fingerprinting (PMF) analysis of the digested peptide samples 
was carried out on an Applied Biosystems Voyager DE-STR (Foster City, CA, USA) 
equipped with a nitrogen laser operated at 337 nm, 3 ns pulse.  The instrument was operated 
in positive ion reflection mode acquiring from m/z 700-m/z 3000.  The samples were 
analyzed as follows:  to the MALDI plate, 0.75 µl of CHCA matrix (5 mg/ml in 75% 
acetonitrile, 0.1% trifluoroacetic acid with 10 mM ammonium phosphate) and 0.75 µl of the 
protein digest was added, mixed on the plate and air dried under a gentle stream of warm air.  
The MALDI plates had previously been mass accuracy optimized with the OptiPlate software 
in the Voyager 5.1 software (Applied Biosystems).  PMF analysis of the digested proteins 
was done in the Automatic Control Mode with recalibrations every 4 samples using a mixture 
of Angiotensin 1 (M+H 1296.6853), ACTH 1-17 (M+H 2093.0867), and ACTH 18-39 (M+H 
2465.1989), and when presented, the spectra were internally calibrated with the autolytic 
fragment from trypsin (MH+ 842.5100 m/z).  200 laser shots were averaged, and then 
smoothed, background corrected and converted to the mono-isotopic values with Data 
Explorer (Applied Biosystems).  The resulting peak lists were submitted to MASCOT for 
database searching.  Proteins that had at least 5 matched peptides with significant protein 
scores were considered to be successfully identified in this study (personal communication 
with Doug Olson [National Research Council’s Plant Biotechnology Institute, Saskatoon, SK, 
Canada]). 
For LC MS/MS, the digested samples were evaporated to dryness, then dissolved in 15 
µl of 1% aqueous trifluoroacetic acid, of which 3 µl was injected on to a NanoAcquity UPLC 
(Waters, Milford, MA, USA) interfaced to a Q-TOF Ultima Global hybrid tandem mass 
spectrometer fitted with a Z-spray nano-electrospray ion source (Waters/Micromass, 
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Manchester, UK).  The peptide digested sample was loaded on to a C18 trapping column 
(Symmetry 180 µm X 20 mm; Waters, Milford, MA, USA) and washed for 3 minutes using 
solvent A (0.1% formic acid in H2O) at a flow rate of 15 μL/min.  The trapped peptides were 
eluted on to a C18 analytical column (1.7 µm BEH130 C18 100 µm X 100 mm; Waters, 
Milford, MA, USA).  Separations were performed using a linear solvent gradient of 
10%:95% to 45%:55% (solvent A:solvent B [0.1% formic acid in acetonitrile]) over 45 min.  
The composition was then changed to 20%:80% (A:B) and held for 10 min to flush the 
column before re-equilibrating for 7 min at 100%:0% (A:B).  Mass calibration of the Q-TOF 
instrument was performed using a product ion spectrum of Glu-fibrinopeptide B acquired 
over the m/z range 50 to 1900.  LC MS/MS analysis was carried out using data dependent 
acquisition, during which peptide precursor ions were detected by scanning from m/z 400 to 
1900 in TOF MS mode.  Multiply charged ions (2+, 3+, or 4+) rising above predetermined 
threshold intensity are automatically selected for TOF MS/MS analysis, by directing these 
ions into the collision cell where they fragment using low energy CID by collisions with 
argon, and by varying the collision energy by charge state recognition, product ion spectra are 
acquired over the m/z range 50 to 1900.  LC MS/MS data was processed using Mascot 
Distiller (ver. 2.1.1.0, Matrixscience) and searched against the NCBInr or Swiss-Prot 
databases using MASCOT (Matrix Science Inc., Boston, MA, USA).  Searches were 
performed using carbamidomethylation of cysteine as a fixed modification and oxidation of 
methionine as a variable modification, allowing for one missed cleavage during trypsin 
digestion.  Proteins that had at least 2 matched peptides with significant scores were 
considered to be identified in this study (personal communication with Doug Olson [National 
Research Council’s Plant Biotechnology Institute, Saskatoon, SK, Canada]). 
 50 
 
4.3. Results 
The 2D electrophoretic pattern of post-suckling plasma (Figure 4.1B) is comparable 
with that of 4-month porcine plasma [151].  The changes in 2D SDS-PAGE protein profiles 
of post-suckling, compared to pre-suckling, whole plasma samples, were dominated by the 
presence of protein spots located in ~50 and 25 kDa region, which represent high and low 
molecular weight chains of colostral immunoglobulins absorbed after suckling (Figure 4.1B).  
Two additional protein spots increased prominently after suckling (Figure 4.1B, spots a and 
b).  Spot a (MW=25 kDa, pI=4) was identified as the immunoglobulin J chain (i.e. the 
joining molecule in IgA and IgM) and spot b (MW=40 kDa, pI=5.3) as apolipoprotein A-IV. 
In plasma samples that were subjected to protein-A affinity chromatography to remove 
immunoglobulins and increase the detection limit, the concentration of immunoglobulins was 
considerably decreased but not eliminated from post-suckling plasma (Figure 4.2B).  
Comparison of two-dimensional electrophoretic pattern of immunoglobulin-removed plasma 
revealed 4 additional protein spots (or groups of spots) that were increased prominently after 
suckling (Figure 4.2B).  They are spot group 7 (MW=47 kDa, pI=5.6~6.5), spot 8 (MW=45 
kDa, pI =4.8), spot group 9 (MW=45 kDa, pI =5.2~6) and spot 10 (MW=17 kDa, pI =6.6).  
All four spots contained fragments of albumin, while one of these, spot 8, contained both 
albumin and haptoglobin (Table 4.1). 
The major proteins in neonatal porcine plasma identified by MS or LCMS/MS are listed 
in Table 4.1. 
4.4. Discussion 
In this study, only the concentrations of immunoglobulins, apolipoprotein A-IV and 
albumin were increased in neonatal porcine plasma after suckling as detected by comparison 
of Coomassie stained two-dimensional electrophoretic patterns of plasma samples obtained 
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from neonatal piglets before and after suckling. 
The absorption of colostral immunoglobulins by neonatal piglets has been well 
characterized previously and was expected in this study.  However, we were surprised by the 
fact that other colostral proteins (e.g. caseins, lactoglobulin and lactalbumin) were not 
absorbed in detectable amounts together with immunoglobulins and that only a few 
non-immunoglobulin proteins (i.e. albumin, haptoglobin and apolipoprotein A-VI) had 
increased moderately in concentration in plasma from piglets after suckling.  It has been 
reported that bovine serum albumin can be absorbed by neonatal pigs [126, 127].  Albumin 
is one of the major porcine colostral proteins [81], thus it is possible that at least some of the 
demonstrated fragments of the albumin in the post-suckling porcine plasma are absorbed 
from colostrum.  Nevertheless, we cannot rule out increased hepatic synthesis of albumin 
stimulated by colostral ingestion as the source.  There is currently no report of the presence 
of haptoglobin in porcine milk.  In a study of acute phase proteins in bovine milk in an 
experimental model of subclinical mastitis caused by Staphylococcus aureus, haptoglobin 
was present in milk from infected cows, but not in milk from control cows [169].  The 
increase of haptoglobin after suckling in this study is thus not likely to be the result of protein 
absorption, but may be due to increase hepatic synthesis.  The increase in apolipoprotein 
A-IV in plasma of piglets after suckling was considered to be a consequence of increased 
hepatic production, because the synthesis of apolipoprotein A-IV was reported to be 
up-regulated by lipid absorption [170], and because its concentration is not detectable in 
Coomassie-stained 2D SDS-PAGE gels of porcine colostrum (data not presented). 
Data generated in this study do not seem to support the previous assumption that protein 
absorption by neonatal piglets within 24-36 h after birth is a non-selective process [122].  
Colostral digestion is limited during the first 24 h due to the low proteolytic activity of 
digestive enzymes in the gastrointestinal tract of the neonates [167] and due to the presence 
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of protease inhibitors in porcine colostrum protecting the degradation of colostral proteins in 
the neonatal intestines [81].  Accordingly, in this study, if substantial non-selective 
absorption was taking place in neonatal intestines, the other major colostral proteins would 
have been absorbed together with immunoglobulins and detected in plasma of neonatal 
piglets after suckling.  Alternative possibilities are that colostral proteins were 
non-selectively taken up by enterocytes and non-immunoglobulin proteins were subsequently 
degraded before being transferred into systemic circulation; or possibly, once absorbed into 
the portal circulation, non-immunoglobulin proteins were removed and degraded by 
hepatocytes, thus were not detected in this study. 
The detection limit of our method needs to be taken into account in this study.  
Coomassie R-250 stain (Bio-Rad Laboratories, Mississauga, ON) that we used for the whole 
plasma has a detection capability of ~50 ng of protein (50 ng protein in 25 μl plasma equals 
to a concentration of 2 mg/L) listed in the manufacturer’s catalogue (Bio-Rad, Life Science 
Research Product Catalog & Price List, Canada, 2008/09, p.162).  Interpreting 
conservatively, i.e. allowing for a 10 fold increase (i.e. 500 ng) in the minimal amount of 
protein detectable by Coomassie R-250 stain, then our study would not detect those proteins 
with a concentration in plasma of less than 20 mg/L.  Accordingly, non-specific absorption 
of some non-immunoglobulin colostral proteins may exist but the amount of proteins 
absorbed by neonates may have been below the detection limit in this study. 
The major proteins (i.e. alpha-1 acid glycoprotein, alpha-2-HS-glycoprotein, 
alpha-fetoprotein, serotransferrin, albumin and immunoglobulin) in neonatal porcine plasma 
composed over 90% of the total proteins as shown in this study (Figure 4.1).  Removal of 
some of these major proteins can improve the visualization of minor plasma proteins.  
Accordingly, we employed Protein-A affinity chromatography to remove immunoglobulins, 
which represent a substantial proportion of the proteins in plasma from the piglets after 
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suckling.  It is interesting that the protein-A column did not remove all the immunoglobulins 
(Figure 4.2 B).  The reason for this phenomenon was not definitely determined, but may be 
due to the different affinities of protein-A to the immunoglobulins from different species [171] 
or some non-identified technical insufficiencies; however, after applied to the column, a 
substantial amount of immunoglobulins was removed from the plasma, which resulted in the 
demonstration of more minor spots than it did in the whole plasma (Figure 4.2).  Further, a 
more sensitive colloidal Coomassie G-250 stain [162] was used for 2D SDS-PAGE of 
immunoglobulin-removed plasma.  Nevertheless, only several additional protein spots were 
detected (Figure 4.2B), all of which had peptides matching albumin, but with lower MW than 
albumin.  Thus, these spots may be fragments of albumin that were generated either in vivo 
after absorption or in vitro during sample processing.  It should be noted that, spot 8 (Figure 
4.2B) was identified to contain both albumin fragments and haptoglobin by LC MS/MS 
(Table 4.1).  Although this spot was at similar location to that of haptoglobin β chain in 
4-month old porcine serum [151], based on significant LC MS/MS data, it is likely that 
albumin fragments and haptoglobin co-exist in this same spot.  As discussed above, the 
increase of haptoglobin may be due to post-suckling hepatic synthesis, but not absorption. 
Our results indicate that only 4 proteins, namely immunoglobulin, albumin, haptoglobin 
and apolipoprotein A-IV, are prominently increased in post-suckling plasma.  This seems to 
contradict previous findings reported by Harada et al [124] that ~ 30 more protein spots were 
found in post-suckling porcine plasma than in pre-suckling plasma.  Accordingly, we also 
compared the numbers of protein spots in whole plasma samples before and after suckling, 
determined by automatic count using a 2D analysis software (ImageMasterTM 2D Platinum 
Version 5.00 (1.1.2), GE Healthcare Bio-Sciences AB, Uppsala, Sweden).  On average, ~ 50 
more protein spots were present in post-suckling whole plasma compared to pre-suckling 
plasma (data not shown), which agrees with the result of Harada et al [124]; however, the 
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great majority of these spots were located in the region of immunoglobulin heavy and light 
chains.  Accordingly, as indicated before, immunoglobulins are the most prevalent proteins 
absorbed from colostrum by neonatal piglets and the absorption of other colostral proteins is 
very limited. 
In conclusion, based on comparison of Coomassie-stained 2D SDS-PAGE gels of 
pre-suckling and post-suckling neonatal porcine plasma, immunoglobulins were the only 
proteins unequivocally demonstrated to be absorbed from colostrum.  The absorption of 
other colostral proteins was either equivocal or not detectable by the methods employed in 
this study.  These results suggest that, unlike immunoglobulins, other major proteins in 
porcine colostrum may not be absorbed into systemic circulation and utilized in their intact 
forms in substantial amounts. 
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Figure 4.1.  Representative images of Coomassie-stained 2D SDS-PAGE of whole 
pre-suckling (A) and 24 h post-suckling (B) plasma.  Immunoglobulins are present in large 
amount after suckling.  Two additional spots (spot a and b) are prominent after suckling.  
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Figure 4.2.  Representative images of Coomassie-stained 2-D SDS-PAGE of 
immunoglobulin-removed pre-suckling (A) and 24 h post-suckling (B) porcine plasma.  
Major plasma proteins (squares) and proteins increased prominently after suckling (ovals) are 
noted.  Protein ID #s correspond to those in Table 4.1.   
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5. General discussion 
The aims of the work presented in this thesis were to investigate the ability of porcine 
MFGM proteins to interact with E. coli F4ac fimbriae and to evaluate the absorbability of 
porcine colostral proteins by neonatal piglets.  Overlay Western Blot technique 
demonstrated that the following porcine MFGM proteins interacted relatively strongly with 
F4ac in vitro: butyrophilin, adipophilin, lactadherin and acyl-CoA synthetase 3.  
Comparison of the two-dimensional electrophoretic protein profiles of plasma obtained from 
neonatal piglets before and after suckling revealed that immunoglobulins are the only 
proteins unequivocally absorbed from colostrum by neonatal piglets. 
Besides their nutritional value, colostrum and milk provide important immunity to the 
neonates in their early stage of lives.  Immunoglobulins are commonly speculated to be the 
most important immune components and exert their protective function locally in the 
gastrointestinal tract and/or systemically after their absorption into the blood stream.  After a 
dam has been exposed to or vaccinated with a specific pathogen, specific immunoglobulins 
against that pathogen are produced by the dam and secreted into colostrum and milk.  After 
ingestion of these immunoglobulins, the neonates are protected against this specific pathogen.  
The importance of immunoglobulins in neonatal protection from infection is well 
characterized and indisputable [166]. 
Recent studies have shown increasingly that non-immunoglobulin proteins in colostrum 
and milk may be involved in host defense functions, e.g., human lactadherin can interact with 
rotavirus in vitro and it is associated with protection of human infants against rotaviral 
infection [61, 62]; casein- and lactoferrin-derived peptides also have bactericidal activities 
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[86, 92].   
While the immune functions of colostral and milk non-immunoglobulin proteins in 
human and bovine milk have attracted active research, those of porcine colostral and milk 
proteins have yet to be explored.  The pre-weaning period in modern pig industry has been 
shortened to improve production.  However, this leads to a decrease of overall uptake of 
milk proteins, which potentially may cause health problems.  Intensive research to 
characterize the innate immune functions of porcine milk proteins may provide aid for the 
further improvement of management in the pig industry.  Previously in our laboratory, the 
porcine skim milk fraction was investigated for its ability to interact with virulence 
components of E. coli.  Several proteins have been shown to be able to bind either F4ac or 
LPS of E. coli in vitro [2, 3].  Further, lactadherin was demonstrated to inhibit the 
attachment of F4ac E. coli to intestinal villi ex vivo [3]; and pepsin-digested lactoferrin to 
possesses anti-bacterial activity against several pathogenic bacteria in pigs [4].   
These results suggest the potential immune importance of non-immunoglobulin proteins 
in porcine milk.  Two F4ac-fimbrial-binding proteins (i.e. lactadherin and fatty acid binding 
protein) identified in porcine skim milk by Shahriar et al [3] are predominantly present on 
MFGM in milk.  In addition, porcine MFGM is able to bind F4 E. coli and inhibit the 
attachment of F4 fimbria to the intestinal brush border [153, 154]; however, the components 
responsible for the anti-attachment activity have not been identified.  Besides lactadherin 
and fatty acid binding protein, there are various other proteins on MFGM of human [78], 
bovine [79, 80] and rat [5] milk.  Based on these data the following hypothesis was created: 
other F4ac-fimbrial-binding proteins exist on porcine MFGM, besides lactadherin and fatty 
acid binding protein. 
Therefore, the interaction of porcine MFGM proteins with E. coli F4ac was tested in 
Chapter 3.  Porcine MFGM proteins were first separated by 1D and 2D SDS-PAGE and then 
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subjected to 1D and 2D Overlay Western Blot in which purified F4ac was used as a probe. 
In SDS-PAGE, reducing agents were added according to the instructions of PAGE 
equipment manufacturer (Bio-Rad Laboratories, Mississauga, ON, Canada) to break down 
disulfide bonds between and within proteins, so that the protein complexes and subunits 
could be separated.  Xanthine dehydrogenase, butyrophilin and adipophilin can form a 
protein complex in native MFGM, thus, it is necessary to separate these proteins by the 
addition of reducing agents.  In 1D SDS-PAGE, mercaptoethanol was used as reducing 
agent, and the migration patterns of porcine MFGM (Figure 3.1, lane 1) are comparable with 
the published bovine 1D gel, in which the complex mentioned above were separated [6].  In 
2D SDS-PAGE, dithiothreitol (DTT) was used as reducing agent, and the monomer of 
xanthine dehydrogenase and adipophilin could be successfully identified by LC MS/MS.  In 
addition, a band (Figure 3.2A, MW=66 kDa, pI=4~4.7) with similar migration pattern of 
butyrophilin [5, 6, 164] was observed.  Although this band failed to be identified by LC 
MS/MS, it is likely to be the monomer of butyrophilin.  All together, the amount of reducing 
agents added in SDS-PAGE in this experiment was able to separate at least partially the 
protein complex of xanthine dehydrogenase, butyrophilin, adipophilin, as well as other 
proteins.  Nevertheless, given that butyrophilin was also present in high MW region (Figure 
3.2A, greater than 200 kDa), the question could arise as to whether this represented 
unreduced protein aggregates.  Similar phenomenon was observed in human MFGM [164] 
and the reason for this was not determined.  It might be an artifact in 2D SDS-PAGE due to 
high concentration of some proteins in the sample [172] or may represent unreduced 
butyrophilin. 
The reason that Overlay Western Blot, instead of affinity chromatography in which 
native samples are applied, was employed to test our hypothesis was to avoid the potential 
false positive results caused by protein complexes in native MFGM formed by disulfide 
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bonds, such as those among butyrophilin, adipophilin and xanthine dehydrogenase [6].  Had 
affinity chromatography been used in this study, and if one of the proteins in the complex 
mentioned above could bind to F4ac, the other two proteins, not necessarily themselves 
F4ac-fimbrial-dinding proteins, would also remain in the column and be eluted together with 
other real F4ac-fimbrial-binding proteins, thus produce false positive results.  In this study, 
prior to Overlay Western Blot, reducing agent was added to the porcine MFGM (during 
SDS-PAGE) to break the disulfide bonds, thus allowing the separation of these three proteins.  
Our results demonstrated that xanthine dehydrogenase does not bind to F4ac, and the other 
two proteins in the complex, butyrophilin and adipophilin, bind to F4ac.  By affinity 
chromatography, on the other hand, all three proteins of this complex would have been 
interpreted to be F4ac-fimbrial-binding proteins. 
Several positive spots were demonstrated by Overlay Western Blot, the signals of which 
ranged from weak to very strong, and some proteins did not react with F4ac at all (e.g. bovine 
serum albumin, xanthine dehydrogenase and serum amyloid A), which can be considered as 
internal negative controls.  Purified porcine lactadherin, which was demonstrated previously 
by affinity chromatography to bind F4ac, was used as a positive control in 1D Overlay 
Western Blot and showed strong reaction with F4ac.  Initially Overlay Western Blot was 
performed with bovine skim milk used as blocking proteins.  In order to eliminate possible 
interference of bovine skim milk proteins in this assay, the Overlay Western Blot was also 
carried out using a protein free blocker and essentially similar results were obtained.  
Further, when F4ac was omitted (omission control), none of the proteins gave positive signal, 
thus it was considered that the positive signals in Overlay Western Blot were given by the in 
vitro reaction between F4ac and porcine MFGM proteins. 
Based on signal intensity demonstrated by Overlay Western Blot, butyrophilin, 
adipophilin, lactadherin and acyl-CoA synthetase 3 were the four major 
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F4ac-fimbrial-binding proteins.  In addition, some fragments of adipophilin also reacted 
strongly with F4ac. 
The results of Overlay Western Blot in Chapter 3 support the previously reported the 
affinity between lactadherin and F4ac [3].  The finding that butyrophilin, adipophilin and 
acyl-CoA synthetase 3 can bind F4ac is novel.  Butyrophilin belongs to the immunoglobulin 
superfamily, which includes various adhesive proteins; however, the previous studies of 
butyrophilin were mainly focused on its association with milk fat secretion [6, 24].  
Similarly, no anti-bacterial functions have been reported in adipophilin and acyl-CoA 
synthetase 3.  The result of this study suggests these proteins may be potentially involved in 
vivo in host defense against pathogens.  Further studies, e.g., an attachment inhibition assay, 
to evaluate the roles of each individual F4ac-fimbrial-binding protein are needed. 
Interestingly, Overlay Western Blot revealed that FABP reacted weakly with F4ac.  
Affinity between F4ac and FABP was previously demonstrated in pepsin-digested porcine 
milk, but not in undigested milk [3].  These phenomena may be explained by the fact that 
the concentration of FABP is low in skim milk and affinity between intact FABP and F4ac is 
low, therefore, it was not detected by affinity chromatography in the previous study when 
non-digested skim milk were employed.  On the other hand, concentration of FABP is high 
in MFGM [6], and therefore, it was detected by Overlay Western Blot in Chapter 3.  It is 
possible that partial pepsin-digestion of FABP generates fragments that have a high affinity to 
F4ac, permitting the detection by F4ac-affinity chromatography in pepsin-digested skim milk 
[3]. 
Several defense proteins in porcine colostrum and milk have been identified and 
characterized.  Some milk proteins, such as IgA, exert their host defense functions locally in 
the gastrointestinal tract by preventing attachment of pathogens to the intestinal surface.  
F4ac-binding proteins identified in Chapter 3 may function as F4ac receptor analogues and 
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also prevent F4-positive E. coli attachment to intestines.  Some other proteins, for example 
IgG and lactoferrin [137], have been demonstrated to provide systemic protection after their 
absorption into the blood circulation [93]. 
The intestinal protein absorption by neonatal piglets within 24-36 h after birth has been 
well accepted to be non-selective [122] based on the previously demonstrated absorption of 
various substances (e.g. bovine serum albumin, dextran and egg proteins) [127, 128].  In 
addition, selective receptor-mediated absorption of immunoglobulin [135], lactoferrin [143] 
and insulin-like growth factor I (IGF-I) [147] by piglets has been also reported and the 
receptors for these proteins are already present at birth.  Harada et al used 2D SDS-PAGE to 
investigate plasma protein profile changes of neonatal piglets after suckling and reported that 
in plasma from post-suckling piglets, ~ 30 more protein spots were present than in plasma 
from pre-suckling piglets [124].  However, the identity of these proteins was not determined.  
Accordingly, experiments in Chapter 4 were performed to identify the changes in plasma 
protein profiles of piglets after natural suckling. 
Comparative 2D SDS-PAGE was chosen to grossly screen the changes of plasma protein 
profiles after suckling.  Whole plasma was first separated by 2D SDS-PAGE and stained by 
Coomassie R-250, which can promisingly detect proteins with concentrations > 20 μg/ml as 
was discussed in Chapter 4.  The 2D electrophoretic pattern of post-suckling plasma (Figure 
4.1B) is comparable with that of 4-month porcine plasma [151].  To our surprise, only 
immunoglobulins were unequivocally demonstrated to be absorbed by piglets within 24 h 
after suckling by comparing the electrophoretic patterns of pre- and post-suckling whole 
plasma.  A large amount of immunoglobulins was present in the plasma after suckling, but 
not in the pre-suckling plasma.  Other major colostral proteins, such as casein, lactoglobulin 
and lactalbumin were not detectable in plasma after suckling. 
In order to demonstrate more minor plasma proteins, protein-A affinity chromatography 
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was employed to remove the immunoglobulins from the plasma.  After passing through the 
protein-A column, a substantial amount of immunoglobulins was removed from the plasma; 
however, it should be noted that the immunoglobulins were not totally removed.  The reason 
of this phenomenon was not definitely determined.  Possible explanations may include 
technical insufficiencies and the different affinities between protein-A and immunoglobulins 
from various species [171].  Additionally, a more sensitive stain, colloidal Coomassie G-250, 
which was reported to be able detect ~1 ng of protein [162], was used to visualize the 
proteins.  The above approaches resulted in the visualization of more minor spots in this 
study (Figure 4.2B).  Only 4 additional protein spots (or groups of spots) were demonstrated 
to increase after suckling (Figure 4.2B).  These spots all contain fragments of albumin, 
which is one of the major proteins in porcine colostrum.  The increase of albumin after 
suckling could be due to absorption, since it was reported that bovine albumin can be 
absorbed by neonatal piglets [126, 127].  The fragments of albumin observed in this study 
are not present in plasma of 4-month pigs [151].  Accordingly, fragments of albumin 
observed in this study may be a result of the absorption of the partial digested albumin from 
the colostrum into systemic circulation.  On the other hand, increased post-suckling hepatic 
synthesis of albumin was also reported [150].  As no antiprotease was used in this study, it is 
also possible that the presence of albumin fragments in post-suckling plasma is an artifact due 
to degradation of the absorbed non-digested and/or increased synthesized albumin during 
sample collection and storage.  Based on current experimental design, it is impossible to 
determine which possibility is a more likely explanation for the presence of albumin 
fragments in post-suckling plasma. 
These results do not support the well accepted concept that protein absorption by 
neonatal piglets is a non-selective process.  There are several major proteins in porcine 
colostrum: immunoglobulins (~126 mg/ml) [81], caseins (~14 mg/g) [173], albumin (~19 
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mg/ml) [174], and lactoglobulin (~7 mg/ml) [175].  If the absorption of intact colostral 
proteins is non-selective, all of these major colostral proteins should have been demonstrated 
in post-suckling porcine plasma; however, only immunoglobulins and albumin are increased 
in neonatal porcine plasma after suckling, while others are not detectable.  Moreover, the 
post-suckling increase of plasma albumin is much less significant compared to that of 
immunoglobulins.  There are five possible explanations for these findings: 1) 
non-immunoglobulin major colostral proteins are not absorbed; 2) non-immunoglobulin 
major colostral proteins can be absorbed, but the degree of absorption is very low, so the 
presence of these proteins in porcine plasma after suckling was not detectable by the methods 
employed; 3) non-immunoglobulin major colostral proteins are absorbed but are removed 
from the portal circulation by the liver; 4) the methods employed were not sensitive enough 
to detect the absorption of minor proteins; or, 5) Protein-A column may have removed minor 
portions of some plasma proteins together with immunoglobulins and produced false negative 
findings (See also Appendix A).  The Coomassie R-250 stain (Bio-Rad Laboratories, 
Mississauga, ON, Canada) we used to visualize the 2D SDS-PAGE of whole plasma can 
detect as little as ~ 50 ng of protein (Bio-Rad, Life Science Research Product Catalog & Price 
List, Canada, 2008/09, p.162).  Divided by the maximum sample load (25 μl) of the 2D 
SDS-PAGE equipment (PROTEAN® II xi Cell, Bio-Rad Laboratories, Mississauga, ON, 
Canada), Coomassie R-250 stain can detect a protein with a concentration of 2 μg/ml (50 ng 
protein in 25 μl plasma equals to a concentration of 2 μg/ml).  Interpreting conservatively, 
i.e. allowing for a 10 fold increase (i.e. 500 ng) in the minimal amount of protein detectable 
by Coomassie R-250 stain, then our method can promisingly detect proteins with 
concentrations > 20 μg/ml in the whole plasma..  Based on this, our detection method should 
have been appropriate to detect the absorption of major colostral proteins into plasma, if their 
absorption is substantial and proportional to that of immunoglobulins.  On the other hand, 
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proteins with low concentrations in colostrum and plasma (e.g. cytokines) cannot be detected 
by our methods, and their absorption was not determined in this study.  This, however, does 
not imply that they are biologically not important.  Thus, within the major colostral proteins, 
only immunoglobulins are absorbed in substantial amounts and utilized by the piglets in their 
intact forms. 
Comparative 2D SDS-PAGE seems not to be a good method to investigate our objective 
in Chapter 4, which was to determine the changes in plasma protein profiles in piglets after 
natural suckling.  This method cannot detect many minor proteins in the samples.  
Removal of major proteins in the samples and chromatographic fractioning of the samples are 
two common solutions for this problem.  In one study, after removal of most of the major 
human plasma proteins by immunoaffinity chromatography and further chromatographic 
fractioning, minor proteins known to have concentrations < 10 ng/ml, such as interleukin-6, 
were able to be visualized by Coomassie stain [176].  This approach, however, is not 
suitable for comparative studies, because it is very difficult to accurately evaluate the original 
concentration of a protein after many chromatographic steps and the antibodies against many 
major porcine plasma proteins are not available.  Quantitative comparative mass 
spectrometry is an alternative choice of achieving our objective.  By this method, the 
developmental changes of bovine MFGM protein profiles have been successfully 
demonstrated [80].  In future studies, this approach can be used to further evaluate the 
changes in plasma protein profiles in piglets after natural suckling. 
In conclusion, the studies present in this thesis demonstrated that there are several 
proteins on porcine MFGM can bind F4ac, and that within the major colostral proteins, 
immunoglobulins are the only proteins absorbed and utilized in large amount and in intact 
form by neonatal piglets. 
This research has extended our knowledge of innate immune substances in porcine milk.  
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The F4ac-fimbrial-binding proteins identified in Chapter 3 may not be the main innate 
defense against pathogenic E. coli, but possibly contribute useful adjunct protection.  Future 
confirmation and characterization of the protective role of each major F4ac-fimbrial-binding 
protein on porcine MFGM is needed.  These proteins can be purified and tested individually 
for their ability to inhibit F4ac E. coli from binding to the porcine intestinal villi ex vivo, as 
was used to characterize the anti-attachment ability of lactadherin [3].  Further, the 
interactions between porcine MFGM proteins, including their fragments, and various 
bacterial and viral pathogens require more study.  Overlay Western Blot can be used as a fast 
screening method to select potential MFGM and milk proteins that interact with pathogens.  
More intense research is needed to determine if non-immunoglobulin defense substances 
identified in porcine milk have potential to be used for future treatment and prevention of 
certain intestinal infections.  Last but not least, since more and more defense proteins have 
been identified from porcine milk, research efforts should be made to investigate whether the 
decreased overall ingestion of these proteins associated with the early weaning time in 
modern swine industry leads to a change of disease prevalence in pigs. 
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Appendix A 
 
Appendix A 
Proteins removed from 24 h post-suckling porcine plasma by protein-A affinity 
chromatography 
 
 
 
Appendix A1.  Colloidal Coomassie G-250 stained 1D SDS-PAGE of the proteins removed 
from 24 h post-suckling porcine plasma by protein-A affinity chromatography.  Five µg 
(lane 1 and 3) and 10µg (lane 2 and 4) of the eluted proteins were separated under reduced 
(lane 1 and 2) and non-reduced (lane 3 and 4) conditions.  By visual estimation, bands 
represent immunoglobulin heavy chain (~ 50 kDa) and light chain (~ 28-31 kDa) compose 
more than 95% of the total proteins in the elutant. 
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Appendix A2.  Colloidal Coomassie G-250 stained 2D SDS-PAGE of the proteins (80 µg) 
removed from 24 h post-suckling porcine plasma by protein-A affinity chromatography.  By 
visual estimation, spots represent immunoglobulin heavy chain (~ 50 kDa) and light chain (~ 
28-31 kDa) compose more than 95% of the total proteins in the elutant. 
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Appendix A3.  Silver-stained 2D SDS-PAGE of the proteins (20 µg) removed from 24 h 
post-suckling porcine plasma by protein-A affinity chromatography.  Several spots not in the 
locations of immunoglobulin heavy chain and light chain were visualized in the elutant.  
These spots may be components of the immunoglobulin molecules and/or sepharose-binding 
proteins in the porcine plasma.   
 89 
 
Appendix B 
 
Appendix B 
Sensitivities of three staining methods 
 
 
Appendix B.  Different amounts of bovine serum albumin (BSA) were separated by 1D 
SDS-PAGE and stained by Coomassie R-250, Colloidal Coomassie G-250 and silver stain.  
Both Coomassie stains were able to detect as little as 50 ng of BSA and silver stain can detect 
down to 0.1 ng BSA. 
